Cover image via U.Today Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.
Pseudonymous crypto analyst Trader Tardigrade has published a bullish outlook for the most popular meme-themed cryptocurrency, Dogecoin, for this year.
The trader believes that, powered by the current bullish reversal on the crypto market, Dogecoin could go up and reach levels close to $2 per coin.
Dogecoin may target $1.60, per analystTrader Tardigrade shared a DOGE/USD chart with a classic example of fractal analysis. The trader spotted a recurring pattern over the past decade, and he told the crypto community that the likelihood of similar explosive Dogecoin growth occurring again is high this year.
HOT Stories
The trader identified the “bullish breakdown” pattern on the chart. A breakdown shows an asset’s price falling below a support line and, thus, showing a bearish sign. The chart shows that before every tremendous bull run staged in 2017 and 2021, the meme coin’s price briefly went down below the local support level. Crypto analysts usually believe that during such price dips, the market shakes out “weak hands” and short-sellers before it starts going up again, leaving those behind.
The analyst’s chart shows that a similar breakdown is taking place at the moment, with DOGE trading at a support zone around $0.07-$0.09 after a 3.4% surge over the past 24 hours. The expected breakout this year, according to Trader Tardigrade, is $1.60 and $2.20. This would significantly exceed Dogecoin’s all-time high of $0.70 reached in May 2021.
You Might Also Like
Reality check for DogecoinHowever, the community should bear in mind that in order to stage a massive price increase like that, the market capitalization value of the meme coin needs to surge from the current $15.68 billion to a mammoth $230 billion. This is close to the market cap of Ethereum, which currently sits at $250 billion. A great amount of new capital will have to flow into Dogecoin, which makes the aforementioned scenario rather unrealistic.
Besides, in 2021, DOGE hit an ATH largely thanks to Elon Musk’s support, which gave DOGE a lot of publicity, including Musk’s debut on the national U.S. TV show Saturday Night Live.
Meanwhile, recently launched Dogecoin ETFs have broken a no-flow streak that lasted for the past 30 days, according to data shared by SoSoValue. As of March 2, those ETFs have inhaled $779,000 from institutional investors.
2026-03-04 14:598d ago
2026-03-04 09:288d ago
CoinDesk 20 performance update: Solana (SOL) gains 5.6%, leading index higher
Bitcoin price jumped to its highest level in over a month as investors reacted to news that Iran had reached out to the United States for talks on ending the war.
Summary
Bitcoin price jumped to $72,000 for the first time in a month. The rally happened amid reports that Iran had reached out to the United States. Still, recent rebounds have turned out to be dead-cat bounces. Bitcoin (BTC) jumped to $72,000, its highest level since February 4, and 20% above the lowest level this year.
However, there is a risk that this rebound could be a bull trap. For one, Iran has rejected reports of potential talks with the United States.
The country hopes to increase damage to US interests in the region, boost crude oil and natural gas prices, and increase damage to Israel. Its leaders believe that doing that will give it an advantage during talks.
Indeed, a Polymarket poll shows that the odds of a ceasefire happening by March 31 dropped by 11% to 38%. Odds of the ceasefire happening by April 30 dropped by 15% to 56%.
The start of talks between the US and Iran would be bullish for Bitcoin and other assets as it would lead to lower inflation. It would also remove the most geopolitical risks from the market.
Meanwhile, Bitcoin price may retreat after Scott Bessent, the Treasury Secretary, hinted that the US will likely implement Trump’s 15% tariff as soon as this week. The tariff will jump from the current 10%, making it hard for companies to do business in the US.
This tariff comes after the Supreme Court ruled that Donald Trump erred when he used emergency powers to implement “reciprocal” tariffs on other countries. These tariffs are based on section 122 that enables the president to implement tariffs that last for 150 days.
Technical analysis suggests that the Bitcoin price may still retreat BTC price chart | Source: crypto.news Recent gains in the crypto market have turned out to be dead-cat bounces or bull traps. A DCB is a situation where a falling asset bounces back briefly and then drops again. For example, the coin rebounded on Monday and then dropped on Tuesday.
Bitcoin is still at risk of further downside as it remains below the Supertrend indicator. It also remains below all moving averages. For a recovery to happen, the coin will need to move above these indicators.
Therefore, while this could be a sign of a new bull run, there is a risk that it will resume the downward trend, and possibly retest the year-to-date low of $60,000.
2026-03-04 14:598d ago
2026-03-04 09:308d ago
Bitcoin's Last Cycle Bottom Shows When The Bleed Will End This Time Around
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure
Crypto analyst Ardi has alluded to Bitcoin’s last cycle to provide insights into when the leading crypto could end its downtrend this time around. This comes as BTC continues to show strength amid the rising tensions between the U.S. and Iran.
Analyst Points To Bitcoin’s Last Cycle Bottom For When This Downtrend Could End In an X post, Ardi noted that during the last cycle bottom, it wasn’t just Bitcoin’s price that found a floor, but that the Open Interest was completely wiped out back then. He highlighted how leverage was reset to zero back then, which was when the real bottom accumulation started. The analyst suggested that BTC may again be on its way to finding a bottom, as the market has already flushed a lot of leverage.
However, he noted that if the last cycle is any guide, the Bitcoin bottom doesn’t form until the speculative excess is almost entirely gone. CoinGlass data shows that leverage in the BTC market remains well above levels recorded at the last cycle’s bottom. Bitcoin’s open interest is currently at $43.86 billion, while the derivatives trading volume is at $87.68 billion.
Source: Chart from Ardi on X Meanwhile, Ardi also commented on the ongoing war between the U.S. and Iran and how it affects Bitcoin. When asked whether his analysis factored in the war for when a bottom could occur, the analyst stated that BTC’s price has already factored in most of that. He added that the worst phase for price is likely over from a war perspective.
Bitcoin has so far maintained a tight range amid the war between the U.S. and Iran. The leading crypto had climbed to $70,000 earlier in the week but faced significant selling pressure at that psychological price level.
BTC Could Rally To $80,000 This Month Crypto analyst Michaël van de Poppe predicted that Bitcoin could rally to between $75,000 and $80,000 this month. The analyst also touched on the current price action, highlighting how it has held above $65,000 and even rallied towards the $70,000 level. He added that BTC is likely to see some days of consolidation before a breakout to the upside likely occurs. This breakout also looks likely, considering that Bitcoin has been establishing this range for a while now.
A positive for Bitcoin is that the selling pressure may be easing. Glassnode analyst Chris Beamish stated that the long-term holders (LTH) net position change is now easing after months of sustained net selling. This suggests that selling pressure from seasoned holders is moderating as BTC stabilizes.
At the time of writing, the BTC price is trading at around $67,800, down in the last 24 hours, according to data from CoinMarketCap.
BTC trading at $69,695 on the 1D chart | Source: BTCUSDT on Tradingview.com Featured image from Pixabay, chart from Tradingview.com
Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.
Sign Up for Our Newsletter! For updates and exclusive offers enter your email.
Scott Matherson is a leading crypto writer at Bitcoinist, who possesses a sharp analytical mind and a deep understanding of the digital currency landscape. Scott has earned a reputation for delivering thought-provoking and well-researched articles that resonate with both newcomers and seasoned crypto enthusiasts. Outside of his writing, Scott is passionate about promoting crypto literacy and often works to educate the public on the potential of blockchain.
2026-03-04 14:598d ago
2026-03-04 09:308d ago
Bitcoin Pattern Memory Predicts The Bottom, And It's Below $40,000
Bitcoin’s market cycles have often followed recognizable technical structures, and one analyst now believes those repeating structures may already be pointing toward the next major bottom.
This is the foundational principle behind why Elliott Wave, Harmonic Patterns, and Wyckoff theory work: trade an asset long enough, and it begins to show a pattern memory. Right now, that memory is speaking. And it’s pointing to a Bitcoin price bottom below $40,000.
Pattern Memory And Bitcoin’s Retracement History A chart shared by market commentator Lisa N Edwards outlined how Bitcoin’s retracement behavior could determine where the current cycle eventually stabilizes during the current downturn. The analysis revolves around the concept of pattern memory, the idea that assets with long trading histories tend to repeat certain behavioral patterns across cycles.
Pattern memory shows that Bitcoin’s previous market cycles have consistently ended near specific Fibonacci retracement levels from the previous peak. These levels have always acted as areas where the Bitcoin price finally found a durable bottom before beginning a new bull phase.
During the 2013 cycle, Bitcoin ultimately formed its bottom near the 0.86 Fibonacci retracement. The 2017 cycle followed a similar structure, once again reaching the 0.86 retracement low before a new accumulation phase began. However, the 2021 market cycle bottom occurred slightly higher, around the 0.786 retracement level.
Bitcoin Price Chart. Source: @LisaNEdwards On X
Bitcoin Pattern Memory: Where Is The Next Real Bottom? If October 2025 was the true cycle high for Bitcoin, as the monthly chart on the 1M timeframe suggests, then history gives us a roadmap for where price is likely headed before the next major bull run begins. Applying the same retracement framework to the current market cycle produces a range where Bitcoin may eventually bottom if history repeats.
Mapping the current cycle’s Fibonacci retracement from the cycle low to the October 2025 high reveals three critical zones. The 0.618 sits at approximately $57,000-$58,000, which also aligns closely with the Weekly 200 Moving Average. However, this level alone may not represent the final low, based on how previous cycles behaved.
Instead, deeper retracement levels appear more consistent with historical patterns. This is where the 0.786 and 0.86 retacements come into play. The 0.786 retracement level sits near $39,000 and coincides with the monthly 100-moving average. Beneath that, the 0.86 retracement level falls around $31,000.
Both levels have previously defined major cycle bottoms; therefore, Bitcoin’s next long-term low could be somewhere within the $39,000 to $31,000 range if the October 2025 peak proves to be the true cycle high.
Some market commentators have floated lower downside targets, including projections that Bitcoin could revisit the $20,000 region. However, the pattern-memory analysis shows that such a drop would represent a complete breakdown of Bitcoin’s historical cycle behavior.
BTC price breaks $71,000 | Source: BTCUSD on Tradingview.com Featured image created with Dall.E, chart from Tradingview.com
2026-03-04 14:598d ago
2026-03-04 09:388d ago
Bitcoin Hits $71,000: Schiff Warns of 'Head Fake' as Tether CEO Sees Green
Cover image via U.Today Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.
Bitcoin, the first and largest cryptocurrency by market capitalization rose above $71,000 on Wednesday, gaining more than 9% in 24 hours and leading broad advances in major cryptocurrencies.
Crypto markets rebounded on Wednesday, recovering from a prior sell-off and shaking off earlier pain in other asset classes.
You Might Also Like
HOT Stories
Bitcoin rallied nearly 9% to reach $71,928, its highest value in nearly a month. It gave up some of its gains, trading up 5.62% daily to $71,343 at press time.
The leading cryptocurrency had weathered a rocky few days since Saturday, at one point dropping as low as $63,019 that day. Since then, investors have largely rallied around digital assets, with spot Bitcoin exchange-traded funds in the U.S. attracting more than $680 million in inflows on Monday and Tuesday, Bloomberg reported.
Bitcoin woke up today and chose green.
— Paolo Ardoino 🤖 (@paoloardoino) March 4, 2026 Bitcoin's rise past $71,000 has attracted reactions within and outside the crypto industry. Tether CEO Paolo Ardoino commented on the Bitcoin price jump: "Bitcoin woke up today and chose green."
Peter Schiff questions BTC's riseIn his usual characteristic manner, longtime cryptocurrency critic Peter Schiff questions Bitcoin's rise, calling it a "head fake."
"Bitcoin is trading above $71,000. This is a head fake. Don't look a gift horse in the mouth. Sell your Bitcoin now and buy gold or silver. You can thank me later," Schiff wrote.
Schiff, a gold bug, has often poured cold water on Bitcoin advances, and at one time claimed Bitcoin could collapse and go down to $20,000, citing the Bitcoin gold divergence to continue.
You Might Also Like
Crypto advocates have often compared Bitcoin to gold, seeing it as a digital safe haven that investors might turn to in volatile times. That narrative failed to stick as Bitcoin fell in recent months while gold rallied. Bitcoin has, however, outperformed gold in recent days, rising 9% since Friday.
Despite the ongoing price rebound, crypto markets remain on edge, with Bitcoin still down about 43% below its October all-time high following a months-long sell-off. This backdrop has put Bitcoin in a unique position, with traders now watching the next move.
2026-03-04 14:598d ago
2026-03-04 09:428d ago
Cardano Volume Jumps 23% as ADA Price Tests $0.30 Resistance
Cover image via U.Today Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.
The crypto market has a completely new lease on life, with Bitcoin and altcoins like Cardano (ADA) recording sharp price gains, per CoinMarketCap data. Specifically, Cardano has seen a visible shift in its on-chain metrics, suggesting that a somewhat bigger rally is ahead.
Cardano on-chain data shiftsOver the past 24 hours, Cardano trading volume has recorded more than a 23% increase. Within this period, the digital currency has seen a total of more than $834 million, shuffled through trading platforms.
With gradual liquidity returning to the market, speculation about how much of an upside it will be for the Cardano price are now growing. By implication, the ADA price is gradually eyeing a retest of the $0.30 resistant level.
As of writing time, the Cardano price is up by 1.55% in the past day and has a spot market price of $0.2668. The last time ADA was priced at $0.30 was Jan. 31, after which it has recorded a series of higher lows under varying market conditions.
Cardano Hourly Price Chart | Source: TradingView/CoinMarketCapWith Cardano open interest always fluctuating and RSI and the moving average teasing a comeback, a retest of the resistance zone might open the ADA price to wilder price rallies.
Role of Midnight networkAmid the growing push for a Cardano rebound, the role of the privacy chain, Midnight Network, is also under review. As the sidechain hinted, the mainnet for the blockchain is on track to be launched later this month, setting a new era of privacy for Cardano.
You Might Also Like
With top federated node validators like Google Cloud and Vodafone now added to the lineup, exposure to the broader Cardano ecosystem is poised to grow. With Midnight, Cardano can have a proxy rival against Zcash and other privacy-focused chains.
While the ADA price is largely considered undervalued, the technical posture and ecosystem trends hint at a big breakout ahead.
2026-03-04 14:598d ago
2026-03-04 09:428d ago
GSR pulls 3,000 ETH from Binance as market liquidity shifts
Market maker GSR has withdrawn 3,000 ETH from Binance, signaling shifting liquidity.
Summary
GSR moved 3,000 ETH, worth about $6.23m, from Binance within 3 hours. On-chain trackers flagged the transfer as part of a broader series of exchange outflows. ETH traded higher alongside BTC, with major assets posting 5%–7% intraday gains. On-chain analytics platform The Data Nerd reported that quantitative trading firm GSR withdrew 3,000 ETH, worth roughly $6.23m, from Binance about three hours ago, marking one of the larger single-address ETH (ETH) outflows from the exchange during today’s session. The move comes as broader crypto markets rebound, with BTC, ETH and other large-cap tokens posting mid-single-digit gains and derivatives data showing signs of reduced leverage on major venues. The withdrawal adds to a growing series of net outflows from centralized exchanges, a pattern often interpreted as either long-term positioning or internal treasury restructuring by market participants.
While GSR has not commented publicly on the transfer, such movements are closely watched because the firm is active across spot and derivatives markets and often acts as a liquidity provider for exchanges and over-the-counter desks. Large withdrawals from trading venues can suggest that holdings are moving to custody or used as collateral in over-the-counter or structured products rather than being deployed for immediate sell-side liquidity. At the same time, exchange balances of ETH have been trending lower this week, even as prices pushed higher alongside BTC, which recently reclaimed the $70k area.
Liquidity flows tighten around ETH The ETH move by GSR coincides with a broader shift in market structure, where on-chain and derivatives metrics point to tightening liquidity conditions and more cautious positioning by leveraged traders. Funding rates on major perpetual swaps have cooled after recent spikes, and liquidations over the past 24 hours were skewed toward short positions, suggesting traders were caught offside by the latest upside move in BTC and ETH. Open interest on key venues has stabilized, while options markets still price in elevated implied volatility around upcoming macro data, indicating that professional traders remain hedged against sudden swings.
For institutional desks, shifting assets off exchanges can also reflect counterparty risk management and a preference for using custodial or prime brokerage setups that aggregate trading access to multiple venues, including platforms such as Coinbase. As more firms integrate stablecoin and on-chain settlement rails with traditional banking partners like Visa, the line between exchange liquidity and off-exchange flows is becoming less distinct. In this environment, large single-address transfers, especially in blue-chip assets like ETH and BTC, serve as signals of how sophisticated actors are managing exposure, collateral, and execution in a market still highly sensitive to macro headlines and regulatory developments such as MiCA.
2026-03-04 14:598d ago
2026-03-04 09:478d ago
Shiba Inu (SHIB) on the Verge of Losing 80 Trillion Exchange Threshold, Will Selling End?
Cover image via U.Today Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.
As the total amount of SHIB held on exchanges continues to drop, Shiba Inu is getting close to a significant change in its on-chain structure. More than two trillion SHIB tokens have been removed from trading platforms, according to recent data, bringing the total exchange reserves closer to the crucial 80 trillion mark.
It is getting betterThis consistent outflow may indicate a progressively better environment for the meme-based cryptocurrency, even though the asset's price performance is still poor.
The quantity of tokens that are easily accessible for sale on trading platforms is represented by exchange reserves. When these reserves fall, it usually means that instead of getting assets ready for liquidation, holders are shifting them into long-term storage or private wallets.
HOT Stories
SHIB/USDT Chart by TradingViewThe decline in exchange balances, in SHIB's case, indicates that some market players might be moving away from active trading and toward holding.
Netflow data also shows that withdrawals are currently greater than deposits. Because fewer tokens are placed directly on exchanges, where they can be sold instantly, this imbalance lessens the pressure to sell right away.
Things will not be easy for SHIBThis does not always result in a price increase, but it does set the stage for price stabilization in the event that demand eventually picks back up.
Technically speaking, SHIB's chart still shows a difficult situation. The asset is still trading below all significant moving averages and forming lower highs as it continues its ongoing downward trend.
You Might Also Like
The price has been drifting toward levels not seen in years, as recent attempts at consolidation have repeatedly failed. Momentum indicators are still low, indicating that buyers have not yet taken back control of the market.
On the other hand, a possible long-term benefit is introduced by the decrease in the exchange supply. There is less circulating liquidity available for quick sales when significant volumes of tokens depart from exchanges.
The decreased supply on exchanges can intensify upward movements if market sentiment improves or new demand enters the market.
The notion that long-term holders are accumulating could be strengthened if the current trend continues and exchange holdings drop below the 80 trillion threshold.
2026-03-04 14:598d ago
2026-03-04 09:498d ago
Ethereum Price Analysis: Will ETH Finally Secure the $2K Breakout?
Ethereum is still trying to transition from capitulation into stabilization, with the price holding above the key $1,800 demand zone while repeatedly pressing into resistance near $2,150. The higher timeframe trend remains bearish, but the short-term structure is improving, so the next clean break from this range will likely set the tone for the next multi-week move.
Ethereum Price Analysis: The Daily Chart On the daily chart, ETH is still trading below the 100-day moving average and the 200-day moving average, and both are sloping lower, which keeps the broader bias bearish. The asset is also respecting a descending channel, and the latest bounce is happening from the lower end of that structure rather than from a reclaimed trend level. The nearest overhead supply remains the $2,300 to $2,400 zone, which has acted as a pivot area during the previous distribution phase.
The most important support remains $1,800, which has been tested and defended after the sharp breakdown. If ETH loses $1,800 on a daily close, the next downside magnets are $1,600 and then $1,400, where prior demand zones sit on the chart. On the upside, a daily reclaim of $2,400 would be the first meaningful step toward shifting structure, with the next major resistance band near $2,800 to $3,000.
ETH/USDT 4-Hour Chart On the 4-hour chart, ETH has been carving out a clear range, with buyers defending the $1,800 support area while sellers repeatedly cap the price near the $2,150 mark. This kind of consolidation after a hard sell-off often becomes a decision point, because liquidity builds at both ends, and the breakout can travel quickly. A clean push above $2,150 that holds would put $2,300 to $2,400 back in play as the next target zone.
If ETH fails again at $2,150 and rolls over, the immediate focus returns to the $1,800 area. The risk with repeated support tests is that each bounce can weaken the bid over time, especially if broader market sentiment stays fragile. A breakdown below $1,800 would likely trigger another volatility expansion move because it removes the main demand shelf that has been absorbing selling pressure.
On-Chain Analysis The exchange reserve chart shows a sustained downtrend in ETH held on exchanges, falling toward roughly 15.9 million ETH. In general, declining exchange reserves are associated with reduced immediate sell-side supply, because fewer coins are sitting on venues where they can be quickly sold. That can support stronger rebounds when demand returns, especially if the price is already basing near support.
The key nuance is timing. During a bear phase, reserve declines can reflect a mix of cold storage withdrawals, staking, and migration to on-chain venues, not necessarily aggressive accumulation. If reserves keep falling while price holds above $1,800 and starts reclaiming resistance, it would strengthen the case for a recovery move. If reserves flatten or begin rising again while ETH remains rejected under $2,150, it can signal renewed distribution and increase the odds of another sweep back into the $1,800 support area.
Tags:
2026-03-04 14:598d ago
2026-03-04 09:508d ago
DDC Enterprise boosts BTC reserves as revenue outlook climbs
DDC Enterprise has increased its BTC holdings to 2,183 coins alongside record guidance.
Summary
DDC Enterprise now holds 2,183 BTC after adding 65 BTC during the latest treasury allocation round. The company guided for 2025 revenue of $39m to $41m, up sharply from prior periods. BTC traded near $72k with 7% daily gains, as on-chain data showed continued ETF and corporate inflows. DDC Enterprise has expanded its bitcoin treasury as it forecasts record revenue for 2025, underscoring how smaller corporates are increasingly adopting BTC as a balance-sheet asset alongside cash and short-term securities. The company disclosed that it now holds 2,183 BTC after purchasing an additional 65 BTC in its latest allocation cycle, pushing the notional value of its holdings into the low nine-figure range at current prices.
Management simultaneously projected full-year 2025 revenue between $39m and $41m, signaling confidence in core operations even as macro conditions and funding costs remain uncertain. This dual move — stronger guidance and a larger BTC position — positions DDC Enterprise as part of the expanding cohort of firms treating bitcoin as both a strategic reserve and a potential hedge against fiat debasement and inflation volatility.
The timing of the purchase coincides with renewed strength in the broader crypto market. BTC has reclaimed the $70k level after a stretch of weakness driven by profit-taking, ETF flow noise, and macro risk-off episodes, while Bitcoin (BTC) spot volumes on major exchanges have risen in tandem with net inflows into U.S. spot ETFs. For DDC Enterprise, locking in additional exposure while prices recover suggests an explicit willingness to live with mark-to-market volatility in exchange for longer-term upside and diversification. The firm joins a wider set of publicly visible corporates — from micro-cap growth names to larger fintechs such as Coinbase — that have incorporated digital assets into their treasury playbook, often alongside credit facilities and structured products that use BTC as collateral.
Corporate treasuries turn to BTC DDC Enterprise’s move fits into a broader pattern where corporate treasurers increasingly consider bitcoin allocations as part of liquidity and duration management rather than as a speculative side bet. In practical terms, this often means carving out a fixed percentage of excess cash for BTC purchases, executed over time via exchanges, desks, or ETF wrappers, then holding those assets in cold storage or with institutional custodians. As more firms integrate digital-asset rails via partners like Visa, operational frictions around settlement, payroll, and vendor payments are gradually declining, making it easier to justify on-chain exposure without disrupting day-to-day cash management.
Market structure also favors this shift. After months of distribution from long-term holders and macro-driven deleveraging, derivatives positioning in BTC has normalized, with funding rates near neutral and open interest rebuilding in a healthier, spot-led fashion. This environment reduces the risk that a single negative catalyst will trigger outsized liquidations, giving corporates like DDC Enterprise slightly more confidence when adding to holdings. Meanwhile, regulators continue to refine rules around custody, accounting, and disclosure, with frameworks such as MiCA in Europe clarifying how listed companies should report digital-asset exposure. For shareholders, the key question will be whether management can balance BTC’s volatility with operational discipline, ensuring that ambitious revenue guidance in the $39m–$41m range is met without undue reliance on asset price appreciation.
2026-03-04 14:598d ago
2026-03-04 09:538d ago
Ripple Prime Goes Live on NSCC Clearing Directory in Key Milestone
Cover image via U.Today Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.
In a recent tweet, Ripple Prime CEO Mike Higgins highlights an important milestone for Ripple Prime following its NSCC directory listing.
Higgins was responding to a tweet by XRP enthusiast "BankXRP," which indicated that Hidden Road (now Ripple Prime) was scheduled to go live on the NSCC directory on March 2, 2026.
"The integration of Ripple and Hidden Road continues to scale. The latest DTCC notice shows Hidden Road (HRFI) officially going live on the NSCC directory March 2, 2026," the tweet read.
HOT Stories
"Ripple Prime's role in bridging TradFi and DeFi will likely move post-trade volume to the XRP Ledger," BankXRP added.
Higgins described this as an important milestone for Ripple Prime, saying that the NSCC directory listing places it inside core clearing infrastructure to support more efficient, reliable capital markets at scale. Amid this key achievement, Higgins touts Ripple Prime as the largest global nonbank prime broker, integrated directly into digital asset and traditional venues around the world.
Important milestone for Ripple Prime. NSCC directory listing places us inside core clearing infrastructure to support more efficient, reliable capital markets at scale. Today, Ripple Prime is the largest global non-bank prime broker, integrated directly into digital asset and…
— Mike Higgins (@mikehiggins) March 4, 2026 In 2025, Ripple completed its acquisition of Hidden Road, now called Ripple Prime, making it the first crypto company to own and operate a global, multi-asset prime broker. RLUSD is being used as collateral for a number of prime brokerage products on Ripple Prime, enhancing its utility and reach as well as the use of XRP.
You Might Also Like
In February, Ripple announced support for Hyperliquid, increasing institutional access to on-chain liquidity. This integration enables institutional clients to access on-chain derivatives liquidity while cross-margining decentralized finance (DeFi) exposures with all other asset classes supported by Ripple Prime, including digital assets, FX, fixed income, OTC swaps and cleared derivatives.
Wrapped XRP to gain institutional momentumXRP Ledger native yield provider Doppler Finance announced today a collaboration with Hex Trust to increase Wrapped XRP (wXRP)'s institutional-grade use cases and to support the advancement of XRP-based financial infrastructure across several blockchains.
You Might Also Like
Hex Trust will provide institutional custody and infrastructure ability to help ensure that wXRP-related products are built with regulated custody standards, which are needed for institutional participation.
2026-03-04 14:598d ago
2026-03-04 09:568d ago
Ripple Price Analysis: XRP at a Make-or-Break Level – Key Zones on USDT and BTC Pairs
XRP is still trading under a broader bearish structure, but the recent price action looks like a base attempt after the sharp drawdown. For buyers, the main job is to reclaim key resistance zones and break the downtrend structure.
2026-03-04 14:598d ago
2026-03-04 09:588d ago
Ethereum price eyes $2,200 as local market structure flips bullish
Ethereum price has begun showing early signs of recovery as local market structure turns bullish. Consecutive higher highs and higher lows above key volume levels now place the $2,200 resistance zone in focus.
Summary
Higher highs and higher lows signal bullish structure shift $1,862 high timeframe support held at value area low $2,200 major resistance becomes next upside target Ethereum’s (ETH) recent price action suggests a shift in short-term momentum after a successful defense of major support. While the broader market remains range-bound, the internal structure has begun to show bullish characteristics.
This shift is raising the probability of a continued move higher toward the next significant resistance level.
Ethereum price key technical points Bullish Structure: Higher highs and higher lows forming above the Point of Control. Key Support Held: $1,862 acted as strong high timeframe demand. Upside Target: $2,200 high timeframe resistance above the value area high. ETHUSDT (4H) Chart, Source: TradingView Ethereum’s current price action reflects an important local structural change. After previously trading in a corrective phase, the asset has begun forming consecutive higher highs and higher lows, a classic signal that momentum may be shifting in favor of buyers. This structural transition occurred as price reclaimed and held above the Point of Control (POC), which represents the area with the highest traded volume within the current trading range.
Holding above the POC typically signals that the market is establishing acceptance at higher prices. When buyers manage to sustain price above such an equilibrium level, it often opens the probability of a continuation move toward the upper boundary of the range.
A key factor supporting this shift was Ethereum’s reaction at the $1,862 high timeframe support level. This region aligns closely with the Value Area Low, a technical level where markets frequently find demand. The strong defense of this zone provided the catalyst for the initial bullish rotation that is now unfolding.
From a market structure perspective, this reaction marked the beginning of the internal trend shift. Buyers stepped in aggressively at support, absorbing selling pressure and pushing price back above key volume levels. The resulting momentum has allowed Ethereum to build a short-term bullish structure within the broader range environment.
Despite this positive development, it is important to note that Ethereum remains confined within a larger trading range on higher timeframes. Range-bound markets often produce multiple internal rotations between support and resistance before a decisive breakout occurs. As a result, short-term bullish expansions can still occur even while the broader structure remains neutral.
The next major technical level to watch is the $2,200 resistance zone, which sits above the current Value Area High. This area represents a significant supply region where sellers previously stepped in. If Ethereum continues to maintain its current bullish structure, price could attempt to test this level in the near term.
However, resistance zones such as $2,200 often attract selling pressure, particularly within range environments. Should price reach this area, the market may encounter renewed supply that could trigger a rotational move back toward support levels.
Volume dynamics will play a key role in determining the outcome. A strong expansion in bullish volume as price approaches resistance would increase the probability of a breakout attempt. Conversely, weakening participation could lead to rejection and continuation of the broader range-bound structure.
Overall, Ethereum’s internal market structure currently favors upside continuation, but the presence of strong overhead resistance means traders should remain cautious.
What to expect in the coming price action If Ethereum maintains higher lows above the Point of Control, the probability of a rally toward the $2,200 resistance zone increases. However, failure to break and hold above this level could trigger another rotation within the broader range, sending price back toward high timeframe support near $1,862.
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / March 4, 2026 / CoTec Holdings Corp. (TSX-V:CTH)(OTCQB:CTHCF) ("CoTec" or the "Company") is pleased to announce the accelerated expiry date of the common share purchase warrants ("Warrants") issued by the Company pursuant to the Listed Issuer Finance Exemption ("LIFE") Offering and Private Placement announced by the Company on May 20, 2025 and completed in tranches on June 18, July 3, July 16 and July 21, 2025 (together the "Financing").
The Company issued an aggregate of 17,339,336 Warrants pursuant to the Financing entitling the holders thereof to purchase one common share of the Company ("Common Share") per Warrant at an exercise price of C$1.20 per Common Share for a period of 18 months following the date of issuance, subject to the Acceleration Clause (as defined herein).
The Warrants are subject to an accelerated expiry provision such that if, for any 15 consecutive trading days during the unexpired term of the Warrants, the closing price of the Common Shares on the TSX-V exceeds $1.35 (the "Acceleration Trigger"), the Company may accelerate the expiry date of the Warrants by way of an announcement ("Acceleration Clause").
The Company hereby advises that the Acceleration Trigger has been met as a result of the closing price of the Common Shares on the TSXV exceeding $1.35 for a period of 15 consecutive trading days ended March 3, 2026. Accordingly, the accelerated expiry date of the Warrants shall be Wednesday, April 10, 2026 ("Accelerated Expiry Date"), being 37 days following the date of this notice. All Warrants that remain unexercised after 5:00 p.m. (Vancouver time) on the Accelerated Expiry Date will expire and become void and of no further force or effect.
To date, 5,132,643 Warrants have been exercised resulting in gross proceeds of $6,159,172 to the Company. If all the remaining 12,206,696 Warrants are exercised, the Company will receive further gross proceeds of approximately C$14,648,036.
About CoTec
CoTec Holdings Corp. (TSX-V:CTH)(OTCQB:CTHCF) is redefining the future of resource extraction and recycling. Focused on rare earth magnets and strategic materials, CoTec integrates breakthrough technologies with strategic assets to unlock secure, sustainable, and low-cost supply chains.
CoTec's mission is clear: accelerate the energy transition while strengthening strategic mineral supply chains for the countries we operate in. By investing in and deploying disruptive technologies, the Company delivers capital-efficient, scalable solutions that transform marginal assets, tailings, waste streams, and recycled products into high-value critical minerals.
From its HyProMag USA magnet recycling joint venture in Texas, to iron tailings reprocessing in Québec, to next-generation copper and iron solutions backed by global majors, CoTec is building a diversified portfolio with long-term growth, rapid cash flow potential, and high barriers to entry. The result is a differentiated platform at the intersection of technology, sustainability, and strategic materials.
Statements in this press release regarding the Company and its investments which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Forward-looking statements in this release include, without limitation, statements relating to the advancement, development, financing and potential construction of the Company's projects and investments; anticipated economic metrics; expected production, permitting, engineering and execution milestones; potential strategic transactions or listings; future investment opportunities; and management's expectations regarding the Company's strategy and growth plans. Such forward-looking statements are based on a number of assumptions, including assumptions regarding the continued advancement of the Company's projects, availability of financing, receipt of required permits and approvals, commodity price assumptions, and general economic and market conditions. Since forward-looking statements address future events and conditions, by their nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks, including, without limitation: risks relating to project development and execution; the ability to obtain financing on acceptable terms or at all; changes in commodity prices; changes in government regulation or policy; permitting and environmental risks; joint venture and counterparty risks; and general economic, market and industry conditions. For further details regarding risks and uncertainties facing the Company, readers are encouraged to review the Company's public disclosure documents, which are available under the Company's SEDAR+ profile at www.sedarplus.ca.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
SOURCE: CoTec Holdings Corp.
2026-03-04 13:598d ago
2026-03-04 08:408d ago
Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis
THE WOODLANDS, TX, March 04, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Nikola Cesarovic, PhD, will present clinical feasibility and outcome data at the Cardiovascular Research Technologies (CRT) 2026 Meeting, happening March 7-10, 2026, in Washington, DC.
The abstract titled, “Novel Technique For Transvascular Peripheral Nerve Neurolysis Using Radiofrequency (RF) Ablation: Clinical Feasibility And Outcomes,” will be presented during the Top Abstract Session (S194) on Saturday, March 7 from 2:18 - 2:24p ET for Hypertension Therapies and Renal Denervation session. Dr. Cesarovic will deliver a six-minute presentation, highlighting clinical feasibility and early outcomes associated with a novel RF-based approach designed to selectively disrupt peripheral nerve activity via a transvascular approach. Autonomix’s technology is engineered to identify and target specific nerve signals, potentially enabling differentiated therapeutic precision compared to conventional ablation techniques.
“This Top Abstract selection underscores the growing clinical interest in precision nerve-targeted therapies and highlights the potential of Autonomix’s platform to enable controlled, transvascular peripheral nerve modulation,” said Dr. Robert Schwartz, Co-Founder and Chief Medical Officer of Autonomix. “We believe these early feasibility findings support the broader applicability of our technology across multiple indications where peripheral nerve signaling plays a critical role.”
CRT is one of the world’s leading educational forums for interventional cardiovascular medicine, with Top Abstract podium selections representing the highest-scoring submissions based on scientific merit, innovation and clinical relevance. For more information, please visit the conference website here.
About Autonomix Medical, Inc.
Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.
We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.
For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.
Forward Looking Statements
Some of the statements in this release are “forward-looking statements,” which involve risks and uncertainties. Such forward-looking statements can be identified by the use of words such as “should,” “might,” “may,” “intends,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “expects,” “plans,” and “proposes.” Forward-looking statements in this press release include expectations regarding the potential effectiveness and clinical benefits of Autonomix's nerve-targeted treatments for pancreatic cancer pain and other conditions.
Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on May 29, 2025, and from time to time, our other filings with the SEC. Forward-looking statements speak only as of the date of this press release and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.
Detroit, Michigan--(Newsfile Corp. - March 4, 2026) - Artificial Intelligence Technology Solutions, Inc. (OTCID: AITX) (the "Company"), a global leader in AI-driven security and productivity solutions, along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today announced that an existing channel partner has ordered two ROSA™ security devices, each powered by SARA™, RAD's agentic AI platform, to complete the detection to guard response architecture at a retail property. The pending deployment is designed to provide continuous edge-based monitoring with intelligent escalation to human guard response only when required, offering a more controlled and cost efficient approach to securing retail environments.
Artist’s depiction of a RAD ROSA security device securing a retail property as part of a detection to guard response architecture powered by SARA.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/5243/286178_aitx-rad-2-rosa-dealer-order-260304-1920x1080.jpg
Retail centers continue to face rising security costs driven by labor inflation, expanding property footprints, and increased after hours exposure. Traditional guard-only models often require continuous on-site presence regardless of actual threat activity, creating significant operating expense. By positioning ROSA devices at key access points and integrating SARA for intelligent analysis and escalation, the security posture shifts from constant manual coverage to continuous autonomous detection with targeted human intervention. This architecture provides retail operators with improved oversight while helping bring greater predictability and discipline to security spending.
Troy McCanna, Chief Revenue and Chief Security Officer at RAD, commented, "The industry is recognizing that placing autonomous detection at the edge and using intelligent AI to determine when human response is necessary is a smarter operational model. Retail operators cannot continue absorbing rising guard costs while maintaining the same coverage expectations. What we are seeing now is a shift toward layered security where technology handles constant monitoring and people are deployed with purpose. That transition is accelerating."
RAD invites security professionals and current and prospective channel partners to experience its full portfolio of solutions in action at ISC West 2026. Attendees will have the opportunity to see live demonstrations, speak directly with RAD leadership and product experts, and learn how autonomous security deployments are being proven, expanded, and scaled across real world environments. Meetings may be scheduled in advance or coordinated onsite throughout the event.
About Artificial Intelligence Technology Solutions, Inc. (AITX)
AITX, through its primary subsidiary, Robotic Assistance Devices, Inc. (RAD), is redefining the nearly $50 billion (US) security and guarding services industry1 through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model. RAD solutions are specifically designed to provide cost savings to businesses of between 35%-80% when compared to the industry's existing and costly manned security guarding and monitoring model. RAD delivers these cost savings via a suite of stationary and mobile robotic solutions that complement, and at times, directly replace the need for human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are developed in-house.
The Company's operations and internal controls have been validated through successful completion of its SOC 2 Type 2 audit, which is a formal, independent audit that evaluates a service organization's internal controls for handling customer data and determines if the controls are not only designed properly but also operating effectively to protect customer data. This audit reinforces the Company's credibility with enterprise and government clients who require strict data protection and security compliance.
RAD is led by Steve Reinharz, CEO/CTO and founder of AITX and RAD, who brings decades of experience in the security services industry. Reinharz serves as chair of the Security Industry Association's (SIA) Autonomous Solutions Working Group and as a member of the SIA Board of Directors. The RAD team also draws on extensive expertise across the sector, including Mark Folmer, CPP, PSP, President of RAD and Chair of the ASIS International North American Regional Board of Directors, Troy McCanna, former FBI Special Agent and RAD's Chief Security Officer, and Stacy Stephens, co-founder of security robotics company Knightscope. Their combined backgrounds in security industry leadership, law enforcement, and robotics innovation reinforce RAD's ability to deliver proven, practical, and disruptive solutions to its clients.
RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time.
AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX's RAD, RAD-R, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staff and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit www.aitx.ai, www.radsecurity.com, www.stevereinharz.com, www.raddog.ai, www.radgroup.ai, www.saramonitoring.ai, and www.radlightmyway.com, or follow Steve Reinharz on X @SteveReinharz.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Artificial Intelligence Technology Solutions, Inc. (the "Company"). The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company's future revenues, results of operations, or stock price.
For purposes of the Company's disclosures, "Artificial Intelligence" refers to machine-based systems designed to operate with varying levels of autonomy that, for a given set of human defined objectives, can make predictions, recommendations, or decisions influencing real or virtual environments. In the context of the Company's business, Artificial Intelligence is deployed primarily within the security services and property management industries to support functions such as detection, analysis, prioritization, communication, and response related to safety, security, and operational events.
The Company delivers these capabilities principally through its SARA™ (Speaking Autonomous Responsive Agent) platform, which serves as the Company's primary agentic artificial intelligence system. SARA is designed to receive and process video, audio, and other sensor data, apply automated analysis and inference, and support actions in accordance with predefined operational objectives and human oversight.
Further note that the Company's Board of Directors oversees the Company's deployment of Artificial Intelligence.
Two stocks are standing out in premarket trading this Wednesday morning. Moderna (Nasdaq: MRNA) is up 8.9% and Ross Stores (Nasdaq: ROSS) is up 6.6% as of 8:00 AM ET, each moving on a distinct catalyst. One is a legal resolution years in the making. The other is a blowout earnings report from one of retail’s most consistent operators.
Moderna: Patent Settlement Clears a Major Overhang Moderna’s surge this morning traces back to a settlement announced Tuesday with Arbutus Biopharma and Roivant Sciences subsidiary Genevant Sciences. The dispute centered on lipid nanoparticle (LNP) delivery technology, the mechanism that makes mRNA vaccines work inside the body. Arbutus and Genevant argued Moderna used their proprietary LNP tech without authorization in its COVID vaccines, Spikevax and mResvia.
Moderna agreed to pay up to $2.25 billion to resolve all worldwide litigation, including a $950 million upfront payment due in July 2026 and a $1.3 billion contingent payment tied to the outcome of a separate government contractor liability appeal. In exchange, Moderna receives a global non-exclusive license to use the LNP technology for infectious disease applications with no future royalties owed.
That last part matters. Moderna’s entire pipeline, from its flu vaccine to its cancer immunotherapy work with Merck, depends on mRNA delivery. Removing the royalty burden and resolving all related litigation gives the company a cleaner runway to commercialize its next wave of products without a legal sword hanging over every approval.
The stock has already had a strong year. Moderna is up 69% year-to-date coming into this morning, rebounding sharply from a low of $22.28 over the past 52 weeks. The settlement adds another reason for investors to reconsider a company that had been written off by many. CEO Stephane Bancel set the tone on the Q4 earnings call in February: “We entered the new year with strong momentum despite the continued challenging environment in the U.S., poised to deliver up to 10 percent revenue growth.”
Ross Stores: Off-Price Retail Firing on All Cylinders Ross Stores reported Q4 results after the close Tuesday that beat on every line that matters. Revenue came in at $6.635 billion, up 12.2% year over year, against an estimate of $6.437 billion. Diluted EPS hit $2.00 versus the $1.85 estimate. Comparable store sales grew 9% in the quarter, on top of a 3% comp gain the prior year. Operating margin landed at 12.3%, above the guided range of 11.5% to 11.8%.
CEO Jim Conroy didn’t undersell it:
“We are pleased to report that business momentum accelerated further in the fourth quarter, with both sales and earnings significantly surpassing our expectations.”
The company also raised its quarterly dividend 10% to $0.445 per share and authorized a new $2.55 billion share repurchase program, a 21% increase over the prior $2.1 billion program. Forward guidance was equally strong, with Q1 comp sales projected at 7% to 8% and full-year EPS guided to $7.02 to $7.36.
The backdrop helps explain the momentum. Consumer sentiment sits at 56.4 on the University of Michigan index, deep in pessimistic territory. When wallets tighten, shoppers trade down, and Ross is exactly where they land. The off-price model is not a defensive play right now. It is an offensive one.
Looking Forward For Moderna, watch whether the FDA’s expected decision on its revised flu vaccine application, due by August 5, becomes the next catalyst. For Ross, the question is whether today’s gains hold as investors digest the full-year guidance. Both moves look grounded in real fundamentals this morning.
Stock futures are slightly higher this morning after two days of volatile trading, as investors assess the potential impact of the conflict in the Middle East; U.S. officials said Iran’s fighting capacity has been diminished while Saudi Arabia said a strike on an oil processing plant caused little damage; oil prices have stabilized after President Donald Trump said that the U.S. would protect oil shipping; bitcoin is surging, lifting crypto stocks along with it; and chip giant Broadcom is set to report earnings after the closing bell. Here's what you need to know today.
Stock Futures Rise as Traders Monitor War Stock futures are ticking higher after a wild few days of trading, as investors keep close tabs on developments in the Middle East. Futures tied to the Dow Jones Industrial Average were up 0.2% recently, while those linked to the S&P 500 and the tech-heavy Nasdaq added 0.3% and 0.5%, respectively. Major indexes closed lower yesterday but well above their intraday lows, as the market rebounded from steep early losses for the second day in a row. At one point Tuesday, the Dow had shed nearly 1,300 points—on track for its worst day since last April's tariff shock—but the blue chip index ended the day down 400 points.
Oil prices stabilized after two days of big gains that were fueled by concerns about supply disruptions, while bitcoin surged. (more on those markets below.) Gold futures were up 1.2% recently at $5,185 an ounce, recovering from a decline yesterday that came on the heels of a big gain on Monday. The yield on the 10-year Treasury note, which can influence mortgage rates and other consumer loans, was at 4.08%, up from 4.06% at yesterday's close.
Iran Conflict Enters 5th Day The conflict in the Middle East moved into its fifth day on Wednesday as U.S. military leaders said that Iran’s ability to launch attacks was declining. U.S. Admiral Brad Cooper, head of U.S. Central Command, said that the U.S. has “severely degraded Iran’s air defenses and destroyed hundreds of Iran’s ballistic missiles, launchers and drones,” according to a Wall Street Journal report. CNN reported that Trump said that Iran’s navy and air force have been “knocked out.” Israel said it has launched another wave of strikes in Iran while also targeting locations in Lebanon. The Saudi Arabia Defense Ministry said an Iranian strike on a Saudi Aramco oil facility caused minor damage that forced a temporary halt in operations, The Journal reported.
Oil Stabilizes After Trump Promises Tanker Protection Oil prices were little changed after rising sharply the past two days, as President Trump promised to provide insurance and possible Navy protection for oil tankers threatened by Iran. West Texas Intermediate futures, the U.S. crude oil benchmark, were recently down 0.5% at around $74 per barrel, after rising 11% over the past two sessions to its highest level since June. Brent crude futures, the international benchmark, were holding steady at around $81.50 per barrel, after gaining 12% the past two days. Goldman Sachs lifted its forecast for oil prices by $10, with the bank now projecting that Brent crude will average $76 a barrel over the second quarter, up from the prior projection of $66 a barrel. Investors are concerned that a sustained rise in oil prices could spark inflation and weigh on economic activity.
Bitcoin Rises Above $70,000, Lifting Crypto Stocks Bitcoin surged overnight to eclipse the $70,000 threshold for the first time since mid-February. Bitcoin traded at around $71,300 recently, up from a low yesterday around $66,300. The rising bitcoin price helped lift stocks tied to cryptocurrencies. Shares of major bitcoin buyer Strategy (MSTR) and crypto exchange Coinbase (COIN) were each up about 7% in recent premarket trading, while bitcoin miners MARA Holdings (MARA) and Riot Platforms (RIOT) added 6% and 4%, respectively.
Broadcom Set to Report Earnings Today Investors will be keeping a close eye on Broadcom (AVGO) results, due after the closing bell, for the latest indication of the state of the AI business. The chipmaker is expected to report adjusted earnings per share of $2.02 on a nearly 29% year-over-year jump in revenue to a record $19.21 billion for its fiscal first quarter, according to estimates compiled by Visible Alpha. Broadcom stock has lost nearly one-quarter of its value from its December high, amid concerns about growing competition, pressures from rising memory prices, and skepticism around the sustainability of AI-driven growth. However, Wall Street analysts have remained bullish on Broadcom, setting a mean target price of around $454. The stock was up about 1% ahead of the opening bell at around $317.
Do you have a news tip for Investopedia reporters? Please email us at
[email protected]
2026-03-04 13:598d ago
2026-03-04 08:418d ago
Are Partnerships and Early Orders Powering Rigetti's Quantum Push?
Key Takeaways RGTI landed $5.7M in orders for two 9-qubit Novera systems and an $8.4M deal for C-DAC.Rigetti partners with C-DAC on hybrid systems and with Quanta Computer.RGTI posted $1.9M Q3 revenues and held $446.9M cash, due to a $350M 2025 equity raise to fund its roadmap. Rigetti Computing (RGTI - Free Report) is steadily positioning itself as a serious contender in scalable superconducting quantum computing, supported by a clear technology roadmap and a growing network of strategic partnerships. The company aims to advance from smaller systems toward 100+ qubit machines with improved gate fidelity, ultimately targeting much larger, fault-tolerant quantum systems in the coming years.
This push is reinforced by collaborations designed to strengthen both technology development and manufacturing scale. For instance, Rigetti’s partnership with India’s Centre for Development of Advanced Computing (C-DAC) focuses on building hybrid quantum-classical systems for national research applications. At the same time, Rigetti's alliance with Quanta Computer, which includes more than $100 million in planned investments from each party over five years, along with an equity stake from the latter, is expected to support manufacturing scale-up and commercialization efforts.
On the commercial front, Rigetti is beginning to move beyond pure research and into early customer deployments that signal rising market traction. In September 2025, the company disclosed purchase orders worth roughly $5.7 million for two of its 9-qubit Novera systems. More recently, Rigetti secured an $8.4 million order to deliver a 108-qubit quantum computer to C-DAC’s Bengaluru center, marking a meaningful step into higher-qubit system deployment for a national research institution.
Financially, the company generated $1.9 million in third-quarter revenues, supported by government-funded programs, cloud-access quantum services and collaborative research projects. Rigetti also ended the quarter with $446.9 million in cash, equivalents and short-term investments and no debt, a position further strengthened by a $350 million equity raise in 2025 that provides a solid liquidity runway as it continues investing in the quantum roadmap.
Peers UpdatesQuantum Computing Inc. (QUBT - Free Report) has enhanced the commercial profile by advancing its integrated photonics roadmap and building early traction across government and enterprise customers. The company is expanding thin-film lithium niobate foundry operations while promoting its room-temperature photonic quantum and optimization platforms, including broader cloud-based access to the Dirac systems. Recent capital raises have materially strengthened the balance sheet, giving it greater financial flexibility to scale manufacturing capacity and support ongoing product commercialization efforts.
Arqit Quantum Inc. (ARQQ - Free Report) has recently strengthened its commercial momentum by expanding deployments of quantum-safe encryption solutions and deepening integrations with telecom operators and enterprise infrastructure partners. The company is scaling its NetworkSecure platform alongside additional cryptographic management tools designed to help organizations transition toward post-quantum security standards.
Arqit has also rolled out new capabilities aimed at automating encryption discovery and identifying potential cryptographic vulnerabilities across enterprise systems. As adoption grows across telecom, government and enterprise customers, the company is gradually repositioning itself as a scalable cybersecurity infrastructure provider rather than a business primarily focused on quantum research.
Rigetti’s Price Performance, Valuation and EstimatesShares of RGTI have gained 12.3% in the past six-month period against the industry’s decline of 21.6%.
Image Source: Zacks Investment Research
From a valuation standpoint, Rigetti trades at a price-to-book ratio of 15.05, above the industry average. RGTI carries a Value Score of F.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Rigetti’s 2026 earnings implies a significant 74.3% improvement from the year-ago period.
Image Source: Zacks Investment Research
The company currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
WESTLAKE, Texas--(BUSINESS WIRE)--The Charles Schwab Corporation announced today that it has scheduled its Institutional Investor Day on Thursday, May 14th. This event, which will be held via live public webcast, is designed to help the investment community keep abreast of recent business developments and the Company’s current strategic focus. The program is scheduled to run from 8:30 a.m. - 2:30 p.m. CT, 9:30 a.m. - 3:30 p.m. ET. Participants will include members of the company’s executive management and senior leadership team.
The event will be accessible at https://schwabevents.com/corporation.
About Charles Schwab
The Charles Schwab Corporation (NYSE: SCHW) is a leading provider of financial services, with 38.7 million active brokerage accounts, 5.8 million workplace plan participant accounts, 2.2 million banking accounts, and $12.15 trillion in client assets as of January 31, 2026. Through its operating subsidiaries, the company provides a full range of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services to individual investors and independent investment advisors. Its broker-dealer subsidiary, Charles Schwab & Co., Inc. (member SIPC, https://www.sipc.org), and its affiliates offer a complete range of investment services and products including an extensive selection of mutual funds; financial planning and investment advice; retirement plan and equity compensation plan services; referrals to independent, fee-based investment advisors; and custodial, operational and trading support for independent, fee-based investment advisors through Schwab Advisor ServicesTM. Its primary banking subsidiary, Charles Schwab Bank, SSB (member FDIC and an Equal Housing Lender), provides banking and lending services and products. More information is available at https://www.aboutschwab.com.
More News From The Charles Schwab Corporation
Back to Newsroom
2026-03-04 13:598d ago
2026-03-04 08:458d ago
Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans
~ Underscores Strategic Execution Plans, Regulatory Risk Mitigation Efforts, Pipeline Prioritization, and the Commercial Potential of PF614 ~
SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 4, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics designed to minimize risk of abuse and overdose, today announced the successful initiation of its live "Ask Me Anything" (AMA) series on March 4, 2024.The event reinforced the Company's commitment to transparency, accessibility, and open dialogue with its community. A replay of the AMA series is available on the Company's website here.
The AMA provided Ensysce shareholders and followers with the opportunity to engage directly with Dr. Lynn Kirkpatrick, Chief Executive Officer of Ensysce, covering topics such as Phase 3 execution and timeline visibility, capital discipline and shareholder alignment, as well as strategic priorities and long-term value creation. The event generated numerous distinct questions, arranged under 3 topics reflecting strong engagement and interest from the community.
"Our recent AMA session provided an important opportunity to engage directly with stakeholders and reinforce the strategic clarity behind our PF614 program," said Dr. Kirkpatrick. "We believe there is significant commercial potential for PF614 and that we are positioning the program to address unmet needs in the marketplace. We remain focused on disciplined execution and transparent communication as we advance these programs toward meaningful milestones."
Key highlights from the AMA included:
PF614-301 timeline sequencing
Efforts to reduce clinical and regulatory uncertainty
PF614, PF614-MPAR & ADHD pipeline prioritization
Potential PF614 commercial opportunities
For those who were unable to have their questions answered, please reach out for future opportunities to investor relations at [email protected].
About Ensysce Biosciences
Ensysce Biosciences is a clinical-stage company with a goal of disrupting the analgesic landscape by introducing a new class of highly novel opioids for the treatment of severe pain. Leveraging its Trypsin-Activated Abuse Protection (TAAP™) and Multi-Pill Abuse Resistance (MPAR®) platforms, the Company is developing unique, tamper-proof treatment options for pain that minimize the risk of both drug abuse and overdose. Ensysce's products are anticipated to provide safer options to treat patients suffering from severe pain and assist in preventing deaths caused by medication abuse. For more information, please visit www.ensysce.com.
Forward-Looking Statements
Statements contained in this press release that are not purely historical may be deemed to be forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 and other federal securities laws. Without limiting the foregoing, the use of words such as "may," "intends," "can," "might," "will," "expect," "plan," "possible," "believe" and other similar expressions are intended to identify forward-looking statements. The product candidates discussed are in clinic and not approved and there can be no assurance that the clinical programs will be successful in demonstrating safety and/or efficacy, that Ensysce will not encounter problems or delays in clinical development, or that any product candidate will ever receive regulatory approval or be successfully commercialized. All forward-looking statements are based on estimates and assumptions by Ensysce's management that, although Ensysce believes to be reasonable, are inherently uncertain. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that Ensysce expected. In addition, Ensysce's business is subject to additional risks and uncertainties, including among others, the initiation and conduct of preclinical studies and clinical trials; the timing and availability of data from preclinical studies and clinical trials; expectations for regulatory submissions and approvals; potential safety concerns related to, or efficacy of, Ensysce's product candidates; the availability or commercial potential of product candidates; the ability of Ensysce to fund its continued operations, including its planned clinical trials; the dilutive effect of stock issuances from our fundraising; and Ensysce's and its partners' ability to perform under their license, collaboration and manufacturing arrangements. These statements are also subject to a number of material risks and uncertainties that are described in Ensysce's most recent quarterly report on Form 10-Q and current reports on Form 8-K, which are available, free of charge, at the SEC's website at www.sec.gov. Any forward-looking statement speaks only as of the date on which it was made. Ensysce undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required under applicable law.
Shannon Devine
MZ North America
Main: 203-741-8811 [email protected]
SOURCE: Ensysce Biosciences
2026-03-04 13:598d ago
2026-03-04 08:458d ago
Elektros' Newly Issued EV Fast-Charging Patent Highlights a Potential Ground-Floor Opportunity in the Global Race to Build Next-Generation Electric Vehicle Infrastructure
New Multi-Port Charging Architecture Signals a Potential Leap Toward Ultra-Fast EV Refueling - Designed to Accelerate Adoption, Improve Infrastructure Efficiency, and Transform the Global Charging Experience
SUNNY ISLES BEACH, FLORIDA / ACCESS Newswire / March 4, 2026 / Elektros Inc. (OTC Pink:ELEK) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,522,100 B1, titled "Multi-Port Charging Assembly for Electric Vehicles."
Click here to view U.S. Patent No. 12,522,100 B1 at the USPTO
This newly issued patent represents a potential advancement in electric vehicle charging technology. The patented multi-port charging architecture is engineered to combine multiple independent power inputs and intelligently manage them through a single charging interface. By addressing structural limitations inherent in traditional single-port charging systems, the technology introduces a new infrastructure model that could significantly enhance how electric vehicles are recharged worldwide.
The Company believes this multi-port charging approach has the potential to dramatically reduce overall EV charging times while maintaining compatibility with existing vehicle standards, positioning the technology as a scalable solution for next-generation global EV infrastructure.
"Our primary objective with this patented technology is to fundamentally redefine the electric vehicle charging experience," said Shlomo Bleier, Chief Executive Officer of Elektros Inc. "We are working toward a future where recharging an electric vehicle from empty to full is comparable to refueling a gasoline vehicle - approximately three to four minutes. With our multi-port charging architecture, our goal is to enable full EV battery recharging in roughly seven minutes, a transformative advancement compared to the approximately one hour required by today's fastest supercharging solutions."
The patent was officially issued on January 13, 2026, includes 20 claims, and benefits from a 713-day patent term extension under 35 U.S.C. §154(b). The invention was developed by Shlomo Bleier and is assigned to Elektros Inc.
Elektros believes the technology may be applicable across a broad range of electric vehicle platforms, including passenger vehicles, commercial fleets, and specialty electric vehicles worldwide.
Forward-Looking Statements
This press release contains forward-looking statements regarding anticipated technological capabilities, performance targets, infrastructure deployment, commercialization plans, and potential market opportunities. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results may differ materially due to factors including technological development challenges, regulatory considerations, capital availability, market acceptance, competitive developments, and broader economic conditions. This communication is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities.
Contact
Elektros Inc. - IR and Media Inquiries
Email: [email protected]
Website: www.elektros.energy
SOURCE: Elektros, Inc.
2026-03-04 13:598d ago
2026-03-04 08:458d ago
Olenox Industries Shares Positive Field Reports as Production Stabilizes
CONROE, Texas, March 04, 2026 (GLOBE NEWSWIRE) -- via IBN -- Olenox Industries Inc. (NASDAQ: OLOX) (“Olenox” or the “Company”), a multifaceted energy company, today announces the Company’s well revitalization efforts are achieving success and hitting production targets. Going forward, the Company plans to bring additional wells into production on a weekly basis.
Since December 2025, the Company has successfully revitalized 10 wells, with 25 more expected to be online by the end of the first quarter. Olenox deployed a dedicated rig in its Wichita field in December 2025, and the Company is pleased with the results in the few months since deployment, according to Olenox CEO Michael McLaren.
“We are pleased with the progress of our workovers and revitalization in our Wichita field. Production has stabilized and our original target of 70 barrels a day is in clear sight,” McLaren said. “We hope to hit or exceed this target by month’s end.”
Since Q4 2025 and continuing into 2026, Olenox has been concentrating on revitalizing its wells with a focus on adding more production each week.
“As we continue our workover effort and drilling, we anticipate this field to outperform our previous expectations,” McLaren added.
Combined with the Company’s drilling program, Olenox will continue to revitalize its wells while looking at new acquisitions to add production. The Company is currently evaluating over 6,000 acres as potential acquisition targets, which hold vast potential for workovers and drilling prospects.
About Olenox Industries Inc.
Olenox Industries Inc. (Nasdaq: OLOX), formerly known as Safe & Green Holdings Corp. (SGBX), is an industrial holding company focused on acquiring, operating, and scaling businesses that provide engineered solutions across industrial, energy, and infrastructure markets. Through its subsidiaries, including Giant Containers, the Company delivers high-quality modular and containerized systems designed for rapid deployment and long-term performance.
Safe Harbor Statement
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company’s ability to successfully bring additional wells into production on a weekly basis, the Company’s ability to revitalize 25 more wells by the end of the first quarter, the Company’s ability to successfully meet or exceed its production target of 70 barrels per day, the Company’s ability to successfully evaluate over 6,000 acres as potential acquisition targets, the Company's ability to maintain compliance with the NASDAQ listing requirements, and the other factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
, /PRNewswire/ -- The board of directors of Johnson Controls International plc (NYSE: JCI), a global technology leader in energy efficiency, decarbonization, thermal management and mission-critical performance, has approved a regular quarterly dividend of $0.40 per share of common stock, payable on April 10, 2026, to shareholders of record at the close of business on March 16, 2026. Johnson Controls has paid a consecutive dividend since 1887.
About Johnson Controls:
Johnson Controls, a global technology leader in energy efficiency, decarbonization, thermal management and mission-critical performance, helps customers use energy more productively, reduce carbon emissions, and operate with the precision and resilience required in rapidly expanding industries such as data centers, healthcare, pharmaceuticals, advanced manufacturing, and higher education.
For more than 140 years, Johnson Controls has delivered performance where it really matters. Backed by advanced technology, lifecycle services and an industry-leading field organization, we elevate customer performance, turn goals into real-world results and help move society forward.
Visit johnsoncontrols.com for more information and follow @Johnsoncontrols on social platforms.
SOURCE Johnson Controls International plc
2026-03-04 13:598d ago
2026-03-04 08:458d ago
GE Vernova: Slot Reservation Arbitrage And GridOS Substrate Can Unlock Alpha By 2028
GE Vernova (GEV) is mispriced as a cyclical OEM, while it is evolving into a single-seller IaaS with a zero-cost capital flywheel. Premium pricing within 43 GW of SRAs, vertical integration with Prolec GE, and a growing gas turbine fleet underpin compounding high-margin recurring revenues through 2035. Risks include potential overcapacity if AI-driven power demand falters and near-term headwinds from offshore wind bans and tariffs, but GEV is contractually shielded by SRAs and customer deposits.
2026-03-04 13:598d ago
2026-03-04 08:468d ago
Lakeland Fire + Safety's Arizona PPE Provides Support to the Phoenix Fire Department for the 10th Consecutive Year
Ongoing Service Highlights a Decade of Exceptional Quality, Support and Trust March 04, 2026 08:46 ET | Source: Lakeland Industries, Inc.
HUNTSVILLE, Ala., March 04, 2026 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that its Arizona PPE Recon, Inc. (“Arizona PPE”) subsidiary, which specializes in personal protective equipment (PPE) care and maintenance services, has marked a milestone with the City of Phoenix, Arizona Fire Department (“Phoenix Fire Dept.”) for ongoing PPE advanced decontamination, inspection and repair services for the 10th consecutive year.
The Phoenix Fire Dept. employs over 1,900 sworn firefighters and more than 400 civilian personnel. As one of the busiest departments in the U.S., it operates 59+ stations, with over 400 firefighters on duty across three shifts. Phoenix Fire provides coverage for an area of approximately 520 square miles, supporting over 1.4 million residents, with the department responding to over 231,000 emergency calls annually.
“Phoenix Fire Dept. was Arizona PPE’s first customer in 2016, and this 10th year of support is a testament to its customer service, attention to detail and efficiency,” said Jim Jenkins, President and CEO of Lakeland Fire + Safety. “This ongoing relationship also highlights that Arizona PPE has become a long-term partner to the Phoenix Fire Dept. by offering verified, standards-based care and maintenance programs for turnout gear with proven processes, documentation, and demonstrated service quality. This renewal reflects ten years of evidence that relentless service quality builds lasting retention and a trusted partnership dedicated to protecting the health and safety of first responders and their families.”
The scope of work includes the maintenance and cleaning of personal protective equipment (PPE) gear in accordance with NFPA 1850 requirements, including documented inspection and care practices designed to help departments maintain gear readiness and support firefighter health and safety.
Arizona PPE is a leading and rapidly expanding UL-certified ISP in the Arizona firefighting services market and provides advanced decontamination, repair, and inspection of firefighting personal protective equipment, along with rental services and sales of cleaning detergents, extractors, and dryers.
About Lakeland Fire + Safety
Lakeland Fire + Safety manufactures and sells a comprehensive line of fire services and industrial protective clothing and accessories for the industrial and first responder markets. In addition, we provide decontamination, repair and rental services that complement our fire services portfolio. Our products are sold globally by our in-house sales teams, our customer service group, and authorized independent sales representatives to a strategic global network of selective fire and industrial distributors and wholesale partners. Our authorized distributors supply end users across various industries, including integrated oil, chemical/petrochemical, automobile, transportation, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high-tech electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry. In addition, we supply federal, state and local governmental agencies and departments, including fire and law enforcement, airport crash rescue units, the Department of Defense, the Department of Homeland Security and the Centers for Disease Control. Internationally, we sell to a mix of end-users directly and to industrial distributors, depending on the particular country and market. In addition to the United States, sales are made into more than 50 foreign countries, the majority of which were into China, the European Economic Community ("EEC"), Canada, Chile, Argentina, Commonwealth of Independent States (“CIS”) Region, Colombia, Mexico, Ecuador, India, Uruguay, Middle East, Southeast Asia, Australia, Hong Kong and New Zealand.
For more information about Lakeland, please visit the Company's website at www.lakeland.com.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995
This press release contains estimates, predictions, opinions, goals and other "forward-looking statements" as that phrase is defined in the Private Securities Litigation Reform Act of 1995. Such statements include, without limitation, references to the Company's predictions or expectations of future business or financial performance as well as its goals and objectives for future operations, financial and business trends, business prospects, and management's expectations for earnings, revenues, expenses, inventory levels, capital levels, liquidity levels, or other future financial or business performance, strategies or expectations, including without limitation our M&A strategy and tariff mitigation plans. All statements, other than statements of historical facts, which address Lakeland's expectations of sources or uses for capital, or which express the Company's expectation for the future with respect to financial performance or operating strategies, can be identified as forward-looking statements. Forward-looking statements involve risks, uncertainties and assumptions as described from time to time in press releases and Forms 8-K, registration statements, quarterly and annual reports and other reports and filings filed with the Securities and Exchange Commission or made by management. As a result, there can be no assurance that Lakeland's future results will not be materially different from those described herein as "believed," "projected," "planned," "intended," "anticipated," "can," "estimated" or "expected," or other words which reflect the current view of the Company with respect to future events. We caution readers that these forward-looking statements speak only as of the date hereof. The Company hereby expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which such statement is based, except as may be required by law.
Investor Relations
Chris Tyson
Executive Vice President
MZ Group - MZ North America
949-491-8235 [email protected]
www.mzgroup.us
2026-03-04 13:598d ago
2026-03-04 08:468d ago
Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates
Stevanato Group (STVN - Free Report) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.2 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +6.06%. A quarter ago, it was expected that this maker of glass vials for COVID-19 vaccines would post earnings of $0.14 per share when it actually produced earnings of $0.16, delivering a surprise of +14.29%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Stevanato, which belongs to the Zacks Medical - Drugs industry, posted revenues of $403.37 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 4.96%. This compares to year-ago revenues of $352.68 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Stevanato shares have lost about 26.8% since the beginning of the year versus the S&P 500's decline of 0.4%.
What's Next for Stevanato?While Stevanato has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Stevanato was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.13 on $311.54 million in revenues for the coming quarter and $0.73 on $1.48 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Drugs is currently in the top 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Zevra Therapeutics (ZVRA - Free Report) , another stock in the same industry, has yet to report results for the quarter ended December 2025. The results are expected to be released on March 9.
This specialty pharmaceutical company is expected to post quarterly earnings of $0.05 per share in its upcoming report, which represents a year-over-year change of +107.5%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Zevra Therapeutics' revenues are expected to be $27.91 million, up 132.6% from the year-ago quarter.
2026-03-04 13:598d ago
2026-03-04 08:468d ago
Crypto Stocks Strategy, Coinbase, and Circle Jump in Premarket Trading Wednesday
Crypto-linked equities are surging in premarket trading Wednesday morning. Strategy (Nasdaq: MSTR) is up 6.7%, Coinbase (Nasdaq: COIN) is up 5.6%, and Circle (NYSE: CRCL) is up 2.9% as of 7:55 AM ET, with Bitcoin providing the fuel for all three moves.
Bitcoin’s Rebound Drives the Rally The primary catalyst is a sharp recovery in Bitcoin prices. Bitcoin closed at $65,769 on March 1 before rebounding to $68,832 on March 2 and hitting $71,500 this morning.
According to CoinDesk’s Wednesday morning report, the climb through $71,000 has been driven by a combination of improving macro sentiment, renewed institutional interest, and easing fears around broader risk-asset selling. That kind of macro tailwind does not stay contained to Bitcoin. It flows directly into every publicly traded company with meaningful crypto exposure.
Why These Three Names Move Together Each of these companies has a distinct but direct link to Bitcoin and crypto market health.
Strategy is the most leveraged play of the three. The company holds 713,502 BTC acquired at a cost basis of roughly $54.26 billion. When Bitcoin moves, Strategy’s balance sheet moves with it in real time. The stock is essentially a leveraged Bitcoin proxy wrapped in a corporate structure. MSTR had already gained 6.48% over the prior week heading into Wednesday, and analysts remain broadly bullish, with 13 buy-equivalent ratings against just one hold and a consensus price target of $394.38.
Coinbase is the largest US crypto exchange, and its revenue is directly tied to trading volume and crypto asset prices. Higher Bitcoin prices tend to bring more retail and institutional activity to the platform. COIN had already gained 12.55% over the prior week, and analysts carry a consensus target price of $250.90 on the stock against Tuesday’s close of $182.36. Our 24/7 Wall St. Price Prediction | COIN Price Prediction for COIN stands even higher, at $295.90.
Circle is the stablecoin story. As the issuer of USDC, Circle benefits when crypto market activity accelerates and demand for digital dollar infrastructure grows. The company just reported a strong Q4 just one week ago on February 25. Revenue came in at $770.23 million, up 77% year over year, with USDC in circulation reaching $75.3 billion. CEO Jeremy Allaire framed the moment clearly on the earnings call:
“The fourth quarter marked another step forward in Circle’s mission to build the infrastructure for an open, programmable internet financial system. USDC adoption continued to expand globally as more enterprises, developers, and public institutions integrated digital dollars into real-world payments, treasury, and onchain financial workflows.”
Circle CEO Jeremy Allaire, Q4 2025 earnings call
CRCL has surged 62.34% over the past week, reflecting both the earnings beat and the broader crypto tailwind.
What to Watch Whether these premarket gains hold into the regular session will depend on whether Bitcoin can sustain its footing above $71,000. Prediction markets currently put the odds of Bitcoin reaching $100,000 by year-end at 37.5%.
2026-03-04 13:598d ago
2026-03-04 08:478d ago
Conduent Named a Leader in NelsonHall's 2026 NEAT Evaluation for Healthcare Payer Agility & Innovation
Costco shares have climbed 17% year-to-date, reaching $1,007.77 to close out March 3rd, a stark contrast to the S&P 500, which is essentially flat at -0.24% YTD. Yet despite that outperformance, broader sentiment around the stock remains cautious, with tariff uncertainty and rising labor costs weighing on investor confidence in the consumer defensive space. The underlying business, however, continues to compound quietly and consistently. Membership renewal rates are holding firm, e-commerce is accelerating, and cash generation is strengthening. With earnings on March 5, 2026 approaching, the setup is in place for Costco to reset the narrative.
Costco’s Membership Flywheel and Digital Momentum Should Drive a Beat The most important thing to understand about Costco’s earnings model is that a significant portion of its profit is essentially pre-collected. Membership fee income hit $1.329 billion in Q1 FY2026, up 14.0% year-over-year, and that revenue stream carries near-100% margins. With 81.4 million paid memberships and a worldwide renewal rate of 89.7%, the fee base is both large and sticky. The September 2024 membership fee increase continues to flow through the income statement, providing a structural tailwind that doesn’t depend on consumer spending behavior.
Beyond membership, Costco’s e-commerce channel is delivering outsized growth. E-commerce comparable sales rose 20.5% in Q1 FY2026, with site traffic up 24% and average order value up 13%. That momentum has been consistent across recent quarters — digital comp sales have ranged from 13.6% to 20.9% over the past four quarters — and shows no sign of plateauing.
The earnings beat track record reinforces the bull case. Costco has beaten EPS estimates in eight consecutive quarters, with surprise margins ranging from 0.86% to 6.32%. Prediction markets are pricing in continued outperformance: Polymarket currently shows a 92.5% probability that Costco beats quarterly earnings, with the market expiring on March 5. Full-year analyst estimates reflect sustained growth, with quarterly earnings growth running at 11.4% year-over-year — well above the broader market average. That combination of recurring revenue visibility, digital acceleration, and a consistent beat pattern positions Costco well heading into Thursday’s print.
The Stock Looks Attractive at Current Levels Costco trades at a forward P/E of 49.75x — a meaningful premium to the broader market. That premium is justified by the earnings growth profile: quarterly earnings growth of 11.4% year-over-year, underpinned by a membership model that generates predictable, high-margin fee income regardless of macroeconomic conditions. The business also carries a return on equity of 30.3%, which reflects the capital efficiency of the warehouse model at scale.
Analyst consensus supports the upside case. The 12-month consensus price target stands at $1,052.94, implying roughly 4.5% upside from current levels. Of the 37 analysts covering the stock, 23 carry Buy ratings versus 12 Holds and just 2 Sells. The stock is currently trading below its 52-week high of $1,062.65, meaning it hasn’t fully recovered from last year’s pullback even as the business has continued to strengthen. With membership income compounding, e-commerce accelerating, and a near-unbroken streak of earnings beats, Thursday’s results represent the most immediate catalyst for the stock to close that gap.
Any word on a Costco special dividend will immediately send the stock higher. Costco has a history of returning excess cash to shareholders through large special dividends, typically every few years when its balance sheet builds significant surplus cash. The company paid $7 per share in 2012, $5 in 2015, $7 in 2017, $10 in 2020, and most recently $15 per share in late 2023, its largest payout ever. These one-time distributions have become a recurring feature of Costco’s capital return strategy and are closely watched by investors, as announcements have historically served as a positive catalyst for the stock.
2026-03-04 13:598d ago
2026-03-04 08:488d ago
Bath & Body Works tops fourth quarter estimates, shares rise
Bath & Body Works Inc (NYSE:BBWI) shares rose more than 6% in premarket trading after the retailer reported fourth quarter earnings and revenue that topped Wall Street’s expectations.
The company reported adjusted earnings per diluted share of $2.05 for the quarter ended January 31, 2026, exceeding the $1.75 consensus estimate. Revenue totaled $2.7 billion, ahead of expectations for $2.6 billion.
Daniel Heaf, Bath & Body Works CEO, highlighted that the company’s Q4 results topped its guidance.
“Since launching the Consumer First Formula in the third quarter, we have moved with urgency to accelerate innovation in our hero categories, refresh and modernize our brand, expand distribution, and simplify our operating model,” Heaf said. “The earlier-than-planned launch on Amazon and the rollout of our new brand identity are clear examples of our team’s focused execution.”
For fiscal 2026, the company expects net sales to decline between 4.5% and 2.5% from fiscal 2025 sales of $7.291 billion.
Full-year earnings per diluted share are projected between $3.00 and $3.25, compared with $3.11 in fiscal 2025. Adjusted earnings per diluted share are forecast in a range of $2.40 to $2.65, compared to adjusted EPS of $3.21 last year.
The 2026 outlook includes interest savings from the redemption of $284 million of January 2027 bonds and assumes no share repurchases. The company expects to generate approximately $600 million in free cash flow.
For the first quarter of fiscal 2026, the company forecasts net sales to decline between 6% and 4% from $1.424 billion a year earlier.
First quarter earnings per diluted share are expected between $0.84 and $0.90, compared with $0.49 in the prior-year period. Adjusted EPS for the quarter is projected between $0.24 and $0.30.
2026-03-04 13:598d ago
2026-03-04 08:508d ago
Elektros Secures Breakthrough U.S. Patent for Revolutionary Multi‑Port EV Charging Architecture - Positioning the Company at the Forefront of the Global Ultra‑Fast Infrastructure Transformation
Newly Issued Patent Aims to Dramatically Compress EV Charging Times While Preserving Compatibility with Existing Vehicle Standards Worldwide
SUNNY ISLES BEACH, FL / ACCESS Newswire / March 4, 2026 / Elektros Inc. (OTC Pink:ELEK) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,522,100 B1, titled "Multi-Port Charging Assembly for Electric Vehicles."
View U.S. Patent No. 12,522,100 B1 at the USPTO
This newly issued patent represents a potential advancement in electric vehicle charging technology. The patented multi-port charging architecture is engineered to combine multiple independent power inputs and intelligently manage them through a single charging interface. By addressing structural limitations inherent in traditional single-port charging systems, the technology introduces a new infrastructure model that could significantly enhance how electric vehicles are recharged worldwide.
The Company believes this multi-port charging approach has the potential to dramatically reduce overall EV charging times while maintaining compatibility with existing vehicle standards, positioning the technology as a scalable solution for next-generation global EV infrastructure.
"Our primary objective with this patented technology is to fundamentally redefine the electric vehicle charging experience," said Shlomo Bleier, Chief Executive Officer of Elektros Inc. "We are working toward a future where recharging an electric vehicle from empty to full is comparable to refueling a gasoline vehicle - approximately three to four minutes. With our multi-port charging architecture, our goal is to enable full EV battery recharging in roughly seven minutes, a transformative advancement compared to the approximately one hour required by today's fastest supercharging solutions."
The patent was officially issued on January 13, 2026, includes 20 claims, and benefits from a 713-day patent term extension under 35 U.S.C. §154(b). The invention was developed by Shlomo Bleier and is assigned to Elektros Inc.
Elektros believes the technology may be applicable across a broad range of electric vehicle platforms, including passenger vehicles, commercial fleets, and specialty electric vehicles worldwide.
Forward-Looking Statements
This press release contains forward-looking statements regarding anticipated technological capabilities, performance targets, infrastructure deployment, commercialization plans, and potential market opportunities. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results may differ materially due to factors including technological development challenges, regulatory considerations, capital availability, market acceptance, competitive developments, and broader economic conditions. This communication is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities.
Contact:
Elektros Inc. - IR and Media Inquiries
Email: [email protected]
Website: www.elektros.energy
SummaryWESCO International is valued using a detailed DCF analysis with explicit WACC and growth assumptions.The WACC is calculated at 8.69%, reflecting a 6.24% cost of debt and 10.29% cost of equity, with a 30.87% debt/69.13% equity structure.Free cash flow growth is benchmarked to the machinery, equipment, and supplies wholesalers' expected annual rate.Valuation inputs are grounded in market-based rates, capital structure, and sector growth forecasts for WCC. Pgiam/iStock via Getty Images
Investment thesis Despite its prior solid performance, WESCO (WCC) currently trades at attractive multiples, which presents upside through the following durable components: structurally embedded data center exposure (2025 sales $4.3B, +50% YOY, approximately 18% of revenue) across sectors and strong ability to pay
17 Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-03-04 13:598d ago
2026-03-04 08:528d ago
Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
Collaboration will evaluate Akeso's cadonilimab in combination with INOVIO's INO-5412 (INO-5401 plus INO-9012) as a potential treatment for glioblastoma (GBM), the most common and aggressive form of brain cancer Novel combination therapy will be studied as part of the Phase II adaptive platform trial known as the INdividualized Screening trial of Innovative Glioblastoma Therapy (INSIGhT), sponsored by the Dana-Farber Cancer Institute Study builds on the previously reported positive Phase II results involving INO-5401 in GBM, adding a novel, first-in-class PD-1/CTLA-4 bi-specific immunotherapy, which potentially provides additional checkpoint inhibition through CTLA-4 binding. , /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso"), and INOVIO (NASDAQ: INO) today announced that they have entered into a clinical trial collaboration and supply agreement to evaluate cadonilimab, Akeso's first-in-class PD-1/CTLA-4 bispecific antibody, in combination with INO-5412, INOVIO's DNA immunotherapy candidate, for the potential treatment of GBM. The combination therapy will be studied as a part of INSIGhT, the innovative Phase II adaptive platform trial sponsored by the Dana-Farber Cancer Institute and conducted with Mass General Brigham Cancer Care, Inc., which is designed to quickly and efficiently find new treatments for GBM. Dosing in the combination therapy trial is expected to begin in the second half of 2026.
Cadonilimab has received marketing approval in China for several indications, including first-line gastric cancer, first-line cervical cancer, and second/third-line cervical cancer, demonstrating effectiveness irrespective of PD-L1 expression status. As the world's first approved bispecific antibody for cancer immunotherapy, cadonilimab has established its clinical value through real-world application and validation across multiple Phase III trials. The drug is currently involved in over 11 Phase III/registration clinical studies including global programs such as a Phase III registrational trial for the first-line treatment of gastric cancer, and a Phase II registrational trial for the second-line treatment of liver cancer in patients who exhibit resistance to immune checkpoint inhibitors (IO).
INO-5412 is composed of INO-5401 and T cell immune activator INO-9012. When combined with a checkpoint blockade, targeted DNA immunotherapy has the potential to overcome the challenges of immune checkpoint therapy alone by stimulating an immune response against tumor antigens and driving T cell infiltration into the glioblastoma tumor microenvironment. In an ongoing Phase II trial in newly diagnosed GBM patients, INO-5401 plus INO-9012 in combination with a PD-1 checkpoint inhibitor elicited robust immune responses that potentially correlate with enhanced survival. The novel combination of INO-5412 with cadonilimab to treat GBM builds on this promising data and could potentially benefit patients by providing additional checkpoint inhibition through CTLA-4 binding.
Dr. David Reardon, Director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute and a professor at Harvard Medical School said, "The INSIGhT trial was designed to help quickly advance cutting-edge treatments for GBM, the most common and aggressive form of brain cancer for which there are few effective treatments currently available or in development. We are excited to include INOVIO and Akeso's novel combination immunotherapy in the trial and welcome their efforts to help improve potential outcomes for patients."
Yu (Michelle) Xia, PhD, founder, chairwoman, president, and Chief Executive Officer of Akeso, said, "We are truly excited to collaborate with INOVIO for the treatment of GBM. We are advancing cadonilimab worldwide through Akeso's 'in-house innovation + global partnership' strategy to realize its breakthrough clinical benefits for patients all around the world across multiple cancer types. By collaborating with INOVIO, we aim to harness the benefit of combining INOVIO's DNA medicine with cadonilimab's dual checkpoint inhibition for the treatment of GBM, a particularly challenging central nervous system malignancy. We also look forward to working with one of the world's leading cancer centers in the clinical development of the new cadonilimab and INO-5412 combination treatment for GBM."
Dr. Michael Sumner, INOVIO's Chief Medical Officer, said, "This collaboration is an important step forward for our cancer immunotherapy research and we are delighted to partner with two trailblazing organizations to advance this promising candidate in our late-stage clinical pipeline. Combining INO-5412 with Akeso's novel checkpoint modality represents an important evolution of our research in GBM, builds on our previous data showing the potential to improve patient outcomes and highlights our ongoing commitment to advancing innovative treatments for diseases with significant unmet need."
Under the terms of the agreement, INOVIO and Akeso will provide support for the INSIGhT study, including supplying their respective therapeutic products, while the investigative sponsors will oversee the day-to-day clinical operations.
About Cadonilimab
Cadonilimab, independently developed by Akeso, is the world's first PD-1/CTLA-4 bispecific immuno-oncology therapy. It has been approved and reimbursed in China for three indications: recurrent/metastatic cervical cancer after platinum-based chemotherapy failure, first-line gastric cancer, and first-line cervical cancer. The drug has also been investigated in over 30 clinical trials spanning more than 20 tumor types. Currently, 11 Phase III or registrational trials are ongoing, with three already having met primary endpoints. With a novel dual-targeting mechanism against PD-1 and CTLA-4, cadonilimab demonstrates superior efficacy and a favorable safety profile compared to combination therapies. It has shown strong anti-tumor activity regardless of PD-L1 status and holds breakthrough potential in IO-resistant and immunologically "cold" tumors.
About INO-5412
INO-5412 is an investigational DNA medicine that combines INO-5401 and INO-9012 into a single vial as a potentially powerful cancer immunotherapy particularly when given in combination with checkpoint inhibitors. INO-5401 plus INO-9012 has been previously investigated as a potential therapeutic treatment targeting a number of cancers, including GBM and cancers exhibiting BRCA1 and BRCA2 mutations. Data from an ongoing Phase II trial in newly diagnosed GBM patients, highlighted in a 2022 oral presentation at the American Society of Clinical Oncology (ASCO), demonstrated that INO-5401 plus INO-9012 in combination with a PD-1 checkpoint inhibitor elicited robust immune responses that potentially correlated with enhanced survival. (Reardon D. et al, ASCO 2022).
INO-5401 encodes for INOVIO's SynCon® antigens for hTERT, WT1, and PSMA, which are antigens The National Cancer Institute has highlighted as important targets and designated as high priorities for cancer immunotherapy development. These three antigens have been reported to be over-expressed and often mutated in a variety of human cancers, including GBM. INO-9012 encodes for IL-12, which is a T cell immune activator.
About Akeso
Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world's first or best-in-class innovative biological medicines. Founded in 2012, the company has established a robust R&D innovation ecosystem centered on its proprietary Tetrabody bispecific antibody platform, ADC (Antibody-Drug Conjugate) technologies, siRNA/mRNA modalities, and cell therapies. Supported by a global-standard GMP manufacturing infrastructure and a highly efficient, integrated commercialization model, the company has evolved into a globally competitive biopharmaceutical focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 26 candidates have entered clinical trials (including 15 bispecific/multispecific antibodies and bispecific ADCs. Additionally, 7 new drugs are commercially available. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
About INOVIO's DNA Medicines Platform
INOVIO's DNA medicines platform has two innovative components: precisely designed DNA plasmids, delivered by INOVIO's proprietary investigational medical device, CELLECTRA. INOVIO uses proprietary technology to design its DNA plasmids, which are small circular DNA molecules that work like software the body's cells can download to produce specific proteins to target and fight disease. INOVIO's proprietary CELLECTRA delivery devices are designed to optimally deliver its DNA medicines to the body's cells without requiring chemical adjuvants or lipid nanoparticles and without the risk of the anti-vector response historically seen with viral vector platforms.
Akeso Forward-Looking Statements
This announcement by Akeso, Inc. (9926.HK, "Akeso") contains "forward-looking statements". These statements reflect the current beliefs and expectations of Akeso's management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso's other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in P.R.China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Akeso's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.
INOVIO Forward-Looking Statements
This press release contains certain forward-looking statements relating to our business, including INOVIO's planned clinical collaboration with Akeso to advance novel combination therapy for GBM, plans for the combination therapy to be studied as part of INSIGhT, the expected timing for dosing in the combination therapy trial to begin in the second half of 2026, as well as the potential benefits of INO-5412 in combination with a checkpoint inhibitor such as cadonilimab. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials, product development programs and commercialization activities and outcomes, the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA medicines, our ability to support our pipeline of DNA medicine products, the ability of our collaborators to attain development and commercial milestones for products we license and product sales that will enable us to receive future payments and royalties, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by us or collaborators, including alternatives that may be more efficacious or cost effective than any therapy or treatment that we and our collaborators hope to develop, issues involving product liability, issues involving patents and whether they or licenses to them will provide us with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether we can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of our technology by potential corporate or other partners or collaborators, capital market conditions, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2024, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, and other filings we make from time to time with the Securities and Exchange Commission. There can be no assurance that any product candidate in our pipeline will be successfully developed, manufactured, or commercialized, that the results of clinical trials will be supportive of regulatory approvals required to market products, or that any of the forward-looking information provided herein will be proven accurate. Forward-looking statements speak only as of the date of this release, and we undertake no obligation to update or revise these statements, except as may be required by law.
SOURCE Akeso, Inc.
2026-03-04 13:598d ago
2026-03-04 08:538d ago
CrowdStrike Holds Steady on Wednesday While GitLab Plunges 9% After Earnings
Two software names, both beaten down heading into earnings night. One delivered. One didn’t. That contrast is playing out in premarket trading this Wednesday morning, with CrowdStrike (Nasdaq: CRWD) holding steady while GitLab (Nasdaq: GTLB) is getting hit hard.
CrowdStrike: Relief Rally After a Rough Stretch Shares of CrowdStrike are up 0.65% in premarket trading as of 8:00 AM ET, a measured but meaningful response after the company reported Q4 FY2026 earnings after the bell on March 3, 2026. Given that the stock had been down roughly 16.5% year-to-date heading into the print, investors weren’t looking for fireworks. They just needed CrowdStrike to show up. We were live-blogging the earnings and were generally impressed. CrowdStrike won’t be up dramatically today, but they also provided strong enough guidance to prevent a sell-off , which many richly-valued software stocks have been unable to accomplish recently.
Revenue came in at $1.305 billion, up 23% year over year, edging past the $1.297 billion consensus estimate. More importantly, the company posted its first-ever quarter of positive GAAP net income at $38.7 million. That’s a milestone investors have been waiting on for years.
The ARR story is what really matters here. Ending ARR hit $5.25 billion, up 24% year over year, with net new ARR of $330.7 million in Q4 alone, up 47% year over year. The Falcon Flex platform, CrowdStrike’s flexible consumption-based licensing model, is becoming a real growth engine, with Falcon Flex ending ARR of $1.69 billion, up over 120% year over year. Think of it as the subscription model that customers actually want to expand rather than cancel.
CEO George Kurtz set the tone on the earnings call:
“FY26 will go down in our history books as CrowdStrike’s best year yet. We achieved $5.25 billion in ending ARR – the fastest and only pure-play cybersecurity software company to achieve this milestone.”
That’s not spin. The numbers back it up. FY27 guidance of $5.867 to $5.928 billion in revenue landed largely in line with what the market expected, and for a stock that’s been under this much pressure, inline is a win. You can read our full pre-earnings breakdown here.
GitLab: Beats on the Quarter, Misses on What Matters GitLab’s situation is more complicated and more painful. Shares are down 8.6% in premarket trading as of 8:00 AM ET, even though the company actually beat on both revenue and earnings for Q4.
Revenue came in at $260.4 million, beating the $252.2 million estimate by 3.25%. Non-GAAP EPS of $0.30 crushed the $0.23 estimate. On the surface, that looks like a solid quarter. But the market is looking forward, not backward, and what it sees ahead is a problem.
FY2027 revenue guidance of $1.099 to $1.118 billion implies growth of roughly 15% compared to FY2026’s growth of 25.81%. That’s a significant deceleration. Worse, Q1 FY2027 non-GAAP EPS guidance came in at just $0.20 to $0.21, well below the prior quarter’s $0.30 print. For a company that still has a long road to sustained profitability, a step backward on forward earnings guidance is exactly the wrong signal. The full-year adjusted EPS guidance was the most troubling aspect of earnings, coming in more than 20% below Wall Street expectations.
GitLab also disclosed that free cash flow declined year over year in Q4 to $41.8 million. That’s not catastrophic, but it adds to the concern when paired with weak forward guidance.
CEO Bill Staples pointed to the company’s AI ambitions as the long-term thesis:
“GitLab sits at the heart of how enterprises build and deliver software. The launch of the GitLab Duo Agent Platform brings intelligent orchestration to the full software lifecycle, with all of the context needed to unlock step-function gains across every task in software engineering.”
The vision is credible. But vision doesn’t offset a profitability guide that moves in the wrong direction when investors are concerned offerings from Anthropic and other rivals will begin compressing margins.
GitLab has been in freefall for months, with the stock down roughly 52.5% over the past year and nearly 29% year-to-date even before this morning’s drop. See our full pre-earnings coverage here.
Two Stocks, Two Very Different Stories Both CrowdStrike and GitLab operate in adjacent software spaces, both had been beaten up heading into earnings, and both actually beat on the quarter. But the market is punishing GitLab and giving CrowdStrike a pass, and the reason is simple: guidance. CrowdStrike’s forward outlook confirmed the growth trajectory is intact. GitLab’s raised serious questions about when, and whether, the profitability story arrives on schedule. Watch whether GTLB finds support near current levels or if selling pressure accelerates as the regular session opens.
2026-03-04 13:598d ago
2026-03-04 08:558d ago
NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 4, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.
2026-03-04 13:598d ago
2026-03-04 08:558d ago
Intuitive Surgical Expands Direct Operational Presence in Europe
Key Takeaways ISRG acquired da Vinci and Ion distribution across Southern Europe to begin direct operations in key markets.ISRG placed 342 da Vinci systems in Europe in 2025 vs 309 in 2024, signaling steady regional demand growth.ISRG launched the Ion platform in Italy and Spain, potentially reducing lung cancer treatment start times. Intuitive Surgical (ISRG - Free Report) has completed the acquisition of the da Vinci and Ion distribution business in Europe in a bid to start direct operations in the region. The company acquired the distribution business run by ab medica, Abex, Excelencia Robótica and their affiliates across Italy, Spain, Portugal, Malta, San Marino and associated territories. The company will operate directly in the majority of Europe, excluding a few countries, with the completion of this acquisition.
Following the acquisition, the business operations have been integrated into ISRG’s European commercial and marketing organization. The direct commercialization in Europe will be led by senior vice president and general manager Dirk Barten.
ISRG’s Price PerformanceShares of ISRG have lost 1.2% since the announcement of the news amid a broader stock market decline due to the ongoing war in the Middle East. The company’s shares have gained 6.6% in the past six months against the industry’s fall of 3.8%. The S&P 500 Index is up 7.4% in the same period.
Image Source: Zacks Investment Research
Intuitive Surgical’s management believes that direct operations in Southern Europe should enable it to support customers in a more agile and integrated way, and bring minimally invasive care to more patients.
More on the NewsAs of 2025-end, Intuitive Surgical’s total installed base across Italy, Spain and Portugal was more than 470 da Vinci surgical systems. The company is also bringing its Ion platform to Europe, with a recent launch in Italy and Spain.
Apart from strong growth in the United States, the company has seen a steady increase in treated patients in ex-U.S. markets over the past decade. The share of patients in the ex-U.S. markets has increased from 23% in 2015 to 35% in 2025, primarily driven by Europe and Asia. The company placed a total of 342 da Vinci surgical systems in Europe in 2025 compared with 309 in 2024. A total of 16 Ion systems were placed in Europe during 2025 compared with 14 in the year-ago period. This demonstrates continued growth potential for ISRG’s robotic surgical systems in Europe.
ISRG received European approval for its most advanced robotic surgery system, da Vinci 5, in July last year. The company has seen strong adoption for da Vinci 5 in the U.S. market, a trend likely to be followed in Europe on the back of the latest technological advancements in the system, like force feedback and case insights.
The company also recently launched the Ion system in Italy and Spain. Per data from ISRG, the Ion system has significantly improved survival for lung cancer patients. The system has reduced the time period to start treatment following detection of lung cancer from more than 200 days with the traditional treatment pathway to 28 days, which can be linked to improved survival. An accelerated treatment initiation for patients should potentially drive a rise in demand for the system.
Amid these potential growth drivers for its systems, ISRG’s direct presence places the company in a better position to meet the needs of its customers in these geographies through improving patient and care team experience, increasing access to minimally invasive care and lowering the total cost of care.
Industry ProspectsPer a report from Markets and Markets, the surgical robots market in Europe was valued at $2.10 billion in 2024, which is expected to witness a CAGR of 14% and reach $5.21 billion in 2031. The growth will be primarily driven by the growing preference for minimally invasive procedures. The rise in the elderly population and incidence of chronic diseases like cancer are boosting demand for surgical procedures, thereby driving demand for robot-assisted surgeries.
ISRG’s strong presence in the robotic surgery space makes it one of the players to gain significantly from this growth in the overall market.
Recent News From ISRGLast month, Intuitive Surgical received FDA clearance for the da Vinci 5 system to be used in certain cardiac procedures, including mitral valve repair and internal mammary artery (IMA) mobilization for cardiac revascularization. It expects a limited number of United States centers to collaborate through 2026 to establish initial da Vinci 5 cardiac programs.
ISRG’s Zacks Rank & Other Key PicksIntuitive Surgical currently sports a Zacks Rank #1 (Strong Buy).
Some other top-ranked stocks from the same medical industry are Globus Medical (GMED - Free Report) , Pacific Biosciences of California (PACB - Free Report) and Edwards Lifesciences (EW - Free Report) .
Globus Medical, sporting a Zacks Rank #1 at present, reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.28, beating the Zacks Consensus Estimate by 20.8%. Revenues of $826 million surpassed the Zacks Consensus Estimate by 4.9%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GMED has an estimated long-term earnings growth rate of 9.6% compared with the industry’s 14% rise. The company beat earnings estimates in the trailing four quarters, with the average surprise being 13.2%.
Pacific Biosciences of California, currently flaunting a Zacks Rank of 1, reported a fourth-quarter 2025 adjusted loss per share of 12 cents, which surpassed the Zacks Consensus Estimate by 36.8%. Revenues of $45 million beat the Zacks Consensus Estimate by 9.4%.
PACB has an estimated earnings decline rate of 1.9% against the industry’s 11.4% improvement. The company beat earnings estimates in the trailing four quarters, with the average surprise being 27.7%.
Edwards Lifesciences, currently carrying a Zacks Rank #2, reported a second-quarter fiscal 2026 adjusted EPS of 58 cents, which missed the Zacks Consensus Estimate by 6.5%. Revenues of $1.57 billion beat the Zacks Consensus Estimate by 2%.
EW has an estimated long-term earnings growth rate of 12.9% compared with the industry’s 14% rise. The company beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 5.5%.
CoreWeave, Inc. reported explosive revenue growth but missed EPS estimates, with losses driven by aggressive infrastructure expansion and surging interest expense. Despite a 25% post-earnings stock drop, I maintain a Buy rating for CRWV, citing a $66.8 billion contracted backlog that underpins multi-year revenue visibility and de-risks growth. CRWV management guides for $12–$13 billion 2026 revenue and expects margins to trough in Q1 before a sequential ramp, supported by long-term customer commitments.
2026-03-04 12:598d ago
2026-03-04 06:568d ago
Three Bitcoin signals show $80K is next BTC price target for bulls
Bitcoin (BTC) bulls are eyeing a move back toward $80,000 in March, with at least three indicators flashing increasing upside momentum.
Key takeaways:
Bitcoin jumped by over 5% toward $72,000 on Wednesday.
Multiple indicators, including a symmetrical triangle, hint at an extended price rally toward $80,000.
Bitcoin invalidates bearish chart patternOn Wednesday, BTC’s price showed signs of invalidating what initially appeared to be a bear pennant.
The BTC/USD pair pierced the pennant’s upper trend line after jumping 5.21% to around $71,900. Its breakout came alongside a rise in trading volume, implying stronger conviction behind the rally.
BTC/USD daily price chart. Source: TradingViewThat simultaneously increased the odds of a symmetrical-triangle bullish reversal.
A symmetrical triangle forms when price makes lower highs and higher lows, compressing into a tightening range.
It resolves when the price breaks either of the trendlines and moves by as much as the pattern’s maximum height.
In BTC’s case, the triangle’s widest range is roughly $63,000 to $71,000–$72,000.
BTC/USD daily price chart. Source: TradingViewA standard measured move above the upper trend line points to about $80,000 in March if the breakout sticks. The level aligns with BTC’s 100-day exponential moving average (100-day EMA, the purple line).
BTC’s next hurdle is the 50-day EMA (red) near $74,400. A rejection there would weaken the breakout and raise the odds of a pullback toward the 20-day EMA (green) around $68,700.
BTC futures gap remains unfilled at $80,000The triangle’s $80,000 measured target also overlaps with an unfilled CME futures gap, turning the area into a clear magnet zone for the bulls.
A CME gap happens because CME Bitcoin futures stop trading over the weekend. If Bitcoin’s spot price moves while the futures market is closed, the latter can reopen at a new level, leaving an empty price zone on the chart.
BTC1! daily price chart. Source: TradingViewAs of Wednesday, that gap has been sitting around $79,660–$81,210 since early February.
Nine of the last 10 CME gaps have been filled since August 2025, which is why traders may view the $79,660–$81,210 region as a high-priority target as spot and futures prices re-align.
Polymarket raises odds of $80,000 Bitcoin in MarchPolymarket, a crypto-based prediction market where users trade contracts on real-world outcomes, is showing a clear bullish shift for BTC in March.
Traders now assign 40% odds that Bitcoin reaches $80,000 on Wednesday, up from 20% a day ago. The $75,000 target carries even stronger conviction at 70%, up from 40% yesterday.
Bitcoin price targets for March. Source: PolymarketAt the same time, the odds of the BTC price reaching $65,000 and $60,000 in March are priced lower than before, suggesting the crowd is trimming downside expectations.
This article does not contain investment advice or recommendations. Every investment and trading move involves risk, and readers should conduct their own research when making a decision. While we strive to provide accurate and timely information, Cointelegraph does not guarantee the accuracy, completeness, or reliability of any information in this article. This article may contain forward-looking statements that are subject to risks and uncertainties. Cointelegraph will not be liable for any loss or damage arising from your reliance on this information.
2026-03-04 12:598d ago
2026-03-04 06:598d ago
Morgan Stanley taps Coinbase and BNY Mellon for custody in proposed Bitcoin ETF
Morgan Stanley taps Coinbase and BNY for custody in proposed Bitcoin ETFBNY to act as administrator, transfer agent and cash custodian for Morgan Stanley’s proposed Bitcoin Trust.Updated Mar 4, 2026, 12:58 p.m. Published Mar 4, 2026, 11:59 a.m.
Morgan Stanley (MS) has filed with the Securities and Exchange Commission (SEC) a prospectus outlining the structure of the proposed Morgan Stanley Bitcoin Trust, revealing that the fund plans to use Coinbase Custody (COIN) and the Bank of New York Mellon (BNY) to safeguard its bitcoin holdings, according to a form S‑1 submitted.
The two institutions will serve as the trust’s bitcoin custodians, responsible for storing the digital assets and facilitating transfers related to share creations and redemptions.
The filing outlines a custody structure designed to mirror traditional institutional standards. Bitcoin will largely be held in offline cold storage vaults, where private keys remain disconnected from the internet to reduce hacking risks. A portion of the assets may temporarily move to trading wallets during ETF creation or redemption activity. The trust notes that custody insurance exists but is shared across customers and may not cover all potential losses.
BNY will also play several additional roles within the ETF structure. The bank will serve as the fund administrator, transfer agent, and cash custodian, handling accounting, shareholder records, and cash flows tied to ETF transactions.
The ETF itself will be structured as a passive vehicle designed to track the price of bitcoin by holding the cryptocurrency directly rather than using derivatives or leverage.
The filing also states that the trust will calculate its net asset value using the CoinDesk Bitcoin Benchmark 4PM New York Settlement Rate, which aggregates trade data from major spot exchanges to determine the daily reference price for bitcoin.
More For You
CoinDesk Research looks into how Pudgy Penguins disrupts traditional toys market via a phygital model. With 2M+ units sold, they scale via global partnerships and events.
What to know:
Disrupting a Stagnant Market: Pudgy Penguins is utilizing a "Negative CAC" model to challenge the traditional $31.7B licensed toy industry by treating physical merchandise as a profitable user acquisition tool rather than just a final product.More For You
Bitcoin hits one-month high near $72,000 as haven demand rises
1 hour ago
BTC jumped to $71,800 as investors turned to haven assets in light of the escalating Middle East conflict and renewed strength in altcoins.
What to know:
Bitcoin climbed to a one-month high of $71,800, approaching the $72,000 level that triggered a rejection in early February.The rally coincided with gains in traditional safe havens, with gold up 1.8% and silver up 5.3% since midnight UTC.Altcoins outperformed majors as risk appetite returned slightly, with tokens like KITE, AERO and TAO posting double-digit gains.
2026-03-04 12:598d ago
2026-03-04 07:008d ago
Solana's Reversal Setup Holds, Yet One Rising Metric Carries a 7–10% Warning
Solana’s Reversal Setup Holds, Yet One Rising Metric Carries a 7–10% Warning Prefer us on Google
Bullish divergence appears as Solana hodlers increase accumulation by 27% since March 1Short-term holder losses shrinking — a setup that historically triggered 7–10% SOL drops$86–$89 resistance now decides whether Solana rebounds toward $101 or falls to $77Solana price has been under pressure for weeks. The token is still down roughly 13% over the past month, reflecting the broader weakness across the crypto market. Yet beneath the surface, a potential reversal structure is quietly building. A bullish divergence on the chart has already triggered a rebound attempt, and long-term holders appear to be positioning for an extended recovery.
However, another metric is rising at the same time. Historically, that metric has preceded corrections of roughly 7% to 10% in Solana’s price. If the pattern repeats, the current rebound could remain choppy before a sustained recovery begins. Understanding which force wins this battle requires looking at the chart first.
Solana’s Bullish Divergence Appears as Long-Term Holders Increase AccumulationThe first sign of a potential reversal comes from Solana’s momentum structure.
Between January 28 and March 1, Solana’s price formed a lower low. During the same period, the Relative Strength Index (RSI) formed a higher low. The RSI measures momentum by comparing recent gains and losses. When price declines but RSI rises, it creates a bullish divergence. This pattern often appears when selling pressure begins to weaken during a downtrend.
After the divergence appeared, Solana attempted a rebound. The price climbed roughly 10% before losing momentum again as broader market volatility returned. Importantly, the structure remains intact because Solana is still trading above the swing low printed on March 1.
SOL Price Structure: TradingView
The recent price action is also flirting with the 20-day Exponential Moving Average (EMA). The EMA is a trend indicator that helps traders identify short-term momentum shifts. An EMA reclaim was seen in early January, when Solana went on to rally roughly 17%, reaching a local high near $148. If the current rebound manages to reclaim this level cleanly, it could again strengthen the case for a broader recovery.
On-chain data also shows long-term holders supporting this setup.
The Hodler Net Position Change metric tracks whether investors holding coins for at least 155 days are accumulating or distributing.
Since the divergence appeared on March 1, this metric has strengthened noticeably. Long-term holders increased their net position change from 642,906 SOL to 819,114 SOL by March 3. That represents an increase of roughly 27% in just two days.
Hodlers Adding: GlassnodeThis rise suggests that experienced investors are adding exposure despite the market’s choppy conditions. But accumulation alone does not guarantee a smooth rebound. Another metric is moving in the opposite direction.
Rising Short-Term Holder Metric Has Historically Preceded CorrectionsWhile long-term investors are accumulating, short-term traders are approaching a critical psychological point. This is visible through the Short-Term Holder Net Unrealized Profit/Loss (NUPL) metric.
NUPL measures whether holders are sitting on unrealized profits or losses. When the metric rises, it means losses are shrinking, and traders are moving closer to breakeven levels. Since February 23, Solana’s short-term holder NUPL has risen from −0.71 to −0.49, a recovery of roughly 31%.
STH NUPL: GlassnodeWant more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.
Even though the metric remains in the capitulation zone, the shrinking losses can create an incentive for traders to exit positions once the price rebounds. History shows how this dynamic can affect Solana’s price.
On February 24, when the short-term holder NUPL climbed to around −0.50, Solana traded near $88. Within three days, the price dropped to $82, a decline of roughly 7%.
A similar event occurred earlier in February. On February 6, Solana traded near $87 when the short-term holder NUPL rose toward −0.70. Within six days, the price dropped to $78, a fall of nearly 10%.
NUPL History: GlassnodeThese historical reactions explain why the rising NUPL metric carries a warning. It does not mean traders are taking profits. Instead, many speculative participants who bought at higher levels may sell simply to reduce losses once the SOL price rebounds.
That dynamic becomes even more important when combined with supply distribution data.
A Major SOL Supply Cluster Could Amplify Selling PressureCost basis distribution helps identify where large groups of investors acquired their tokens. This data reveals a significant cluster between $86.80 and $87.80 ($86-$88 zone), where approximately 14.19 million SOL was accumulated.
Cost basis represents the average price investors paid for their holdings. When price approaches these levels, traders who bought earlier often sell to exit their positions near breakeven. Because short-term holders are already approaching loss-reduction territory, this cluster could act as a powerful resistance zone.
Solana Cost Basis Heatmap: GlassnodeIf Solana rebounds toward this range, traders who are trying to reduce losses may sell into the rally. That behavior could reinforce the historical 7–10% pullback pattern seen earlier this month. In other words, the supply cluster and the rising short-term holder NUPL are pointing to the same risk.
But the Solana price chart itself provides the clearest roadmap for what happens next.
The $86–$89 Zone Now Decides the Next Solana Price MoveSolana is currently trading near $83, placing it just below the key resistance zone identified by cost-basis data.
The first hurdle sits near $86, which also aligns with the 20-day EMA. A decisive close above $86 would suggest buyers are gaining strength.
However, the more important level lies slightly higher.
A sustained move above $89 would signal that Solana has cleared the nearest supply cluster without triggering heavy selling. If that happens, the price could extend toward $92, $96, and potentially $101. But failure to break this resistance would support the historical NUPL pattern.
Solana Price Analysis: TradingViewIf Solana loses support near $82, the Solana price could quickly revisit $77. A decline of that size would represent roughly a 7–10% correction, closely matching the pullbacks seen earlier this month.
For now, Solana’s reversal structure remains intact. But as history shows, the path higher may not be smooth.
Disclaimer
In line with the Trust Project guidelines, this price analysis article is for informational purposes only and should not be considered financial or investment advice. BeInCrypto is committed to accurate, unbiased reporting, but market conditions are subject to change without notice. Always conduct your own research and consult with a professional before making any financial decisions. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.
2026-03-04 12:598d ago
2026-03-04 07:018d ago
Lens Protocol Maps Post-Acquisition Roadmap Under Mask Network Stewardship
Mask Network reveals Lens Protocol priorities after January takeover: fixing login issues, wallet integration, and creator monetization before any token launch.
Mask Network has outlined its first concrete roadmap for Lens Protocol since completing the acquisition from Avara in January, prioritizing basic usability fixes over token speculation during a February 21 AMA that revealed significant infrastructure challenges inherited from the previous team.
The session, featuring Mask founder Suji Yan and Lens Product Head Kimmo Siren, addressed why the protocol went silent for six months—legal negotiations prevented both parties from speaking publicly. The transfer is now "99.9% complete," though legacy issues like recent storage data incidents related to domain problems continue surfacing.
Three-Phase Fix ListYan didn't sugarcoat the current state. "There are many, many problems that are very obvious to fix," he said, starting with a login session that expires every seven days. "That might make sense for DeFi apps, but no major social app logs users out every week."
The immediate priorities break down simply: fix usability issues, improve wallet integrations, then pursue growth. Storage limitations currently prevent large multimedia uploads—a problem the team is addressing through partnerships with both centralized and decentralized storage providers.
Wallet compatibility remains a friction point. While Lens Chain operates as a standard EVM chain, many wallets either don't support it properly or lack basic UI elements like icons. "Most users probably don't want to manage assets on Lens Chain," Yan explained. "They just need the private key for login."
No Token Anytime SoonWhen asked about a $LENS token for governance, Yan was blunt about market conditions: "Right now, 99% of tokens in the market are trading below their last VC round valuation." Lens's last private valuation sat around $350 million.
Instead, the team is exploring non-speculative governance mechanisms—potentially using soulbound tokens or weighting voting power based on user behavior rather than token holdings. "If someone spams a lot, their weight goes to zero," Yan suggested.
Creator Economy Reality CheckThe AMA turned candid when discussing content creator adoption. Yan claimed most decentralized social builders lack relationships with professional creators, citing his own connections to adult content creators including "Hong Kong Doll," who reportedly earned $20-30 million during COVID and commands 4 million followers—"more users than Farcaster and Lens combined."
The team plans to implement DMCA tagging for piracy concerns, acknowledging that true decentralization prevents content deletion at the protocol level. Frontend labeling and blurring represent the practical compromise.
On rewards programs, Yan dismissed points-based systems as farming bait. Instead, he referenced a Token2049 partnership with Haidilao hotpot restaurants that distributed dining coupons—a mechanism professional farming operations couldn't exploit economically.
Technical UpdatesSiren confirmed no planned protocol changes to smart contracts, with improvements focusing on backend infrastructure. Mini-apps are "coming to Orb pretty soon," built on QR-based login flows allowing cross-app authentication. The ML scoring model hasn't been updated in over a year and will be overhauled.
The V3 contracts remain marked "unlicensed"—a legacy issue Yan expects to resolve within weeks, likely moving to MIT or GPL licensing.
For builders waiting on the sidelines, Yan offered a simple calculation: posting on Lens can now cost less in gas fees than Twitter's API charges for AI agents, which approach one cent per post. "At some point, developers may start thinking: I should decentralize more of my stack to reduce platform access costs."
Image source: Shutterstock
lens protocol mask network decentralized social web3 deso
2026-03-04 12:598d ago
2026-03-04 07:028d ago
Bitcoin ETFs Pull In $225M With BlackRock Leading Inflows; Ethereum Funds Turn Negative
Bitcoin: Bitcoin ETFs drew $225.2M in inflows, with IBIT leading and reinforcing strong institutional demand. Ethereum: Ethereum ETFs saw a $10.8M net outflow as inflows into ETHA were outweighed by redemptions from FETH and ETHE. Altcoins: Solana and XRP ETFs posted modest but positive flows, signaling selective interest beyond Bitcoin.
Institutional positioning in crypto investment products split sharply on March 3, as Bitcoin ETFs continued to draw steady demand while Ethereum-linked vehicles saw renewed weakness. The broader market traded near recent highs, yet sentiment stayed cautious, creating a backdrop where investors leaned toward the most liquid assets even as prices hovered near key psychological levels.
Bitcoin Inflows Strengthen as Market Approaches Key Thresholds Bitcoin ETFs recorded strong activity, with combined net inflows of $225.2 million, highlighting persistent institutional appetite. BlackRock’s iShares Bitcoin Trust (IBIT) led all Bitcoin ETFs with $322.4 million in new capital, reinforcing its dominance in the category. The inflows helped offset outflows from competing Bitcoin ETFs, including Fidelity’s FBTC, which saw $89.3 million leave the fund, and Grayscale’s GBTC, which recorded $28.2 million in redemptions. Smaller issuers contributed modest gains, with Valkyrie’s BRRR adding $11.6 million and WisdomTree’s BTCW bringing in $8.7 million. The overall trend suggests Bitcoin ETFs remain a preferred entry point as Bitcoin trades near $71,200.
Ethereum Products Face Renewed Outflows Ethereum-linked ETFs moved in the opposite direction, posting a net outflow of $10.8 million. BlackRock’s ETHA generated $41.9 million in inflows, but the strength was outweighed by withdrawals from Fidelity’s FETH, which lost $66.7 million, and Grayscale’s ETHE, which saw $4.7 million in redemptions. Grayscale’s secondary product, ETH, added $18.7 million, softening the decline. Despite Ethereum trading around $2,000 and gaining nearly 6% over the week, demand for its ETFs lagged behind Bitcoin ETFs, reflecting a more cautious stance toward the asset.
Solana ETF Activity Remains Modest Solana ETFs posted $0.7 million in net inflows, with Franklin Templeton’s SOEZ accounting for the entire figure. Other Solana products, including Bitwise’s BSOL and VanEck’s VSOL, reported flat flows. Solana traded near $87.41 with solid daily and weekly gains, yet institutional participation through ETFs remained limited compared with Bitcoin ETFs and Ethereum products.
XRP ETFs Attract Selective Institutional Interest XRP-linked ETFs recorded $7.53 million in net inflows, led by Bitwise’s product with $6.08 million. Canary’s ETF added $1.45 million, while others remained flat. XRP traded near $1.37 and maintained a market capitalization above $83 billion. Although sentiment indicators stayed subdued, the steady allocations across Bitcoin ETFs and other products show institutions continue to favor regulated crypto exposure.
2026-03-04 12:598d ago
2026-03-04 07:038d ago
Corporate and Exchange Demand Drives Surge in Ethereum Staking Queue
Ethereum staking demand rises with 3.4M ETH waiting to join validators. Corporates and exchanges are staking ETH for yield instead of selling. Large investors such as big companies and the crypto exchanges are increasingly choosing to stake Ethereum instead of selling it during the weak market. According to the data from the ValidatorQueue, around 3.4 million ETH is currently waiting to be activated as a validator on the Ethereum network. The current queue means new participants may wait about 60 days before their staking becomes active.
Staking Demand increases The increase in the validator queue suggests that the large investors are locking their ETH to earn staking rewards. Analysts say that a long-term investment strategy is being initiated by staking ETH. Pav Hundal says that many entities joining the staking queue are the large companies and crypto exchanges that want to generate returns from the crypto reserves.
To become a validator on Ethereum, participants must lock 32 ETH. Validators help to secure the network by verifyingtransactions and maintaining blockchain integrity. However, the network limits how quickly new validators can join. Recent network improvements with the Pectra upgrade allow large staking operators to manage bigger amounts of ETH more efficiently by combining stakes into fewer validators.
For institutional investors holding a large amount of ETH, it generates yields without selling the asset, and it also maintains exposure to ETH price growth. When investors stake those coins, they are temporarily removed from the circulating supply. If demand for ETH remains strong while more tokens are locked in staking. The rising validator queue suggests a growing shift among the large investors towards long-term participants in Ethereum’s ecosystem.
Highlighted Crypto News:
Robinhood Chain Testnet Hits 4M Transactions in Week One
2026-03-04 12:598d ago
2026-03-04 07:038d ago
XRP could hit $1,000 with full institutional adoption, according to analyst
The price of XRP could reach $1,000 by the end of 2026, if full institutional adoption and regulatory clarity improves in major jurisdictions, particularly the United States.
This bold prediction was made by Jake Claver, CEO of Digital Ascension Group, during a recent interview on Paul Barron’s podcast.
According to Claver, XRP’s price could hit three to four digits, which would peg the token’s market cap at nearly $60 trillion, assuming a circulating supply ranges between 57 billion and 60 billion coins.
“I’ll say three or four digits, you know, in that range,” Claver stated in the Barron’s podcast posted on February 27, 2026.
XRP price to $1,000 bolstered by full-scale institutional adoption In the interview, Claver highlighted that the exponential bull case scenario for XRP in 2026 will be catalyzed by the mainstream adoption from banks and other institutional investors. Claver quoted Monica Long, President at Ripple Labs, who states that XRP’s growth in 2026 will be driven by full-scale institutional adoption.
As such, Claver stated that XRP will need to absorb billions of dollars through its investment products, led by spot Exchange-Traded Funds (ETFs) and Digital Assets Treasuries (DATs), to be adopted by banks. Furthermore, Claver noted that banks are not interested in high volatility, which is currently associated with XRP’s low valuation.
“If you have a huge market cap for XRP, something much higher than people can comprehend, it will be very difficult to move that price with the inflows or outflows. And if you have stability, I think that is what the adoption curve is waiting on, for the banks want a high stable value,” Claver added.
Who could potentially adopt Ripple’s product? According to Claver, the mainstream adoption of XRP by banks and institutions is awaiting the ultimate clarity in the United States. Already, the United States Securities and Exchange Commission (SEC) has ruled XRP is not a security following the collapse of the Ripple lawsuit.
He stated that banks and institutions will use XRP through products developed by Ripple including Hidden Road, now Ripple Prime. Specifically, the full-scale adoption of XRP will be led by BNY Mellon, Fidelity, Citi, Franklin Templeton, and JPMorgan.
2026-03-04 12:598d ago
2026-03-04 07:058d ago
Bitcoin under pressure: Oil and the Fed dictate the trend
The financial market is going through a period of strong turbulence. Indeed, international tensions are shaking the global economy. Currently, Bitcoin is experiencing significant instability. Analysts observe that macroeconomics now drives the course of this digital currency. Consequently, technical fundamentals matter much less today. Investors are closely monitoring global political decisions instead. Ultimately, these external factors dictate the overall trend across the entire sector.
In brief Geopolitics takes control of the markets: tensions in the Middle East, soaring oil prices, and falling stock indexes heavily weigh on Bitcoin. Rising oil fuels inflation and pushes the Fed to maintain a strict monetary policy, which reduces liquidity and slows down the momentum of bitcoin and risky assets. Institutionals withdrawing: despite some recent inflows, major investors remain cautious, increasing volatility and weakening the entire crypto market. Geopolitical tensions: the impact on Bitcoin’s price Recent attacks in the Middle East worry traditional markets. First, the bitcoin price slid below $65,000 this weekend. Then, buyers quickly brought the price back up to $67,000. However, the Strait of Hormuz remains completely closed to commercial ships.
In its article posted on X, the algorithmic trading firm Wintermute estimates that this maritime blockade prolongs the current international crisis. The airspace above the Gulf region experiences severe restrictions.
On one hand, some political leaders hope for a very quick resolution. However, other officials foresee a much longer conflict. Moreover, traditional finance reacts strongly to these unexpected events. The oil barrel gains 9% almost instantly, according to reports. Gold adds a trillion to its total valuation very rapidly. Meanwhile, the US stock index falls sharply. In summary, fear spreads among all global economic actors, Wintermute’s report indicates.
Oil, Fed and Bitcoin: inflationary pressure weakens markets First, the surge in oil reignites global inflation and increases the energy bill. Wintermute reports that the barrel recently surpassed $80, with projections up to $100. In this context, more expensive energy mechanically causes a widespread price increase. This inflationary dynamic is settling durably and weighs on the cost of living.
Consequently, digital assets are not spared. Bitcoin indirectly undergoes this macroeconomic pressure, often underestimated by traders. Thus, the high energy cost slows investment appetite and strengthens risk aversion.
Then, facing persistent inflation, the US Federal Reserve adopts a wait-and-see stance. Rate cuts are postponed, which has frozen financial markets for several months. As a result, this monetary caution penalizes stocks and directly affects the crypto sector. Maintaining high benchmark rates limits liquidity access and reduces the appeal of risky assets. Ultimately, bitcoin moves at the pace imposed by traditional finance, while hopes of monetary easing gradually fade.
Institutional investors desert cryptocurrency Wintermute notes that capital flows show highly contradictory directions. Last week, index funds attracted a billion dollars. However, annual withdrawals still exceed 4.5 billion dollars in total. Demand from major financial players remains negligible currently. Trading volume plunges compared to last autumn’s peaks. Moreover, price fluctuations increase quite spectacularly. The volatility index jumps strongly on specialized platforms.
weekly Cross-asset performance from January 05 to March 01 Daily fluctuations astonish many financial experts today. Meanwhile, speculators massively buy protection contracts against declines. Finally, alternative currencies struggle to find a durable positive rebound. The vast majority of secondary tokens show rather disappointing results. In summary, the absence of professionals weakens this entire financial ecosystem.
The virtual market is going through a very complex and uncertain period. Nevertheless, current prices already reflect much bad macroeconomic news. The bitcoin price has lost 45% since its all-time high. Speculators flee the sector quickly during major drops. Conversely, long-term holders wisely keep their portfolios.
Looking ahead, analysts identify a very strategic buying zone. A token priced between $40,000 and $50,000 attracts experts’ attention. This level offers an intriguing profit potential over about eighteen months. In conclusion, moderation guides all strategies amid current global crises.
Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.
Join the program
A
A
Lien copié
Ghiles A.
Journaliste et rédacteur web passionné par l’univers des cryptomonnaies et des technologies Web3. J’y traite les dernières tendances et actualités afin de proposer un contenu de haute qualité à un large public du secteur.
DISCLAIMER
The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.
2026-03-04 12:598d ago
2026-03-04 07:108d ago
Ethereum retains RWA lead as liquidity goes multichain, Hong Kong tokenizes real estate
RWA tokenization has been established on multiple chains, with some networks already specializing to carry specific assets and provide liquidity infrastructure.
RWA tokenization is evolving as some projects specialize and concentrate on selected chains. Currently, tokenized assets are a multi-chain phenomenon, spanning several ecosystems.
Based on the number of holders, Ethereum is the leader in adoption, based on tokenized commodities. Ethereum is the leader due to the growing interest in XAUt, the tokenized gold offering by Tether.
Solana has been established as the venue for tokenized stocks, based on the success of XStocks. ONDO also remains a tokenization hub, though with a lower number of owners. Most of the tokens are held on the three leading public chains, Ethereum, Solana, and BNB Chain.
RWA holder count by sector & chain
Tl;dr: RWAs are a multichain phenomenon
A chart to follow 👇 pic.twitter.com/8x851UAoVh
— Token Terminal 📊 (@tokenterminal) March 4, 2026
The distribution of holders stresses the importance of liquidity and easy access to infrastructure for RWA to take off. Currently, there are chains with a much higher asset count, but much lower adoption.
All chains showed growth in the value of tokenized assets, due to appreciation or additional token minting. | Source: RWA.xyz While Canton is a leader in raw tokenization, some assets are more actively traded and more prominent on social media. The availability of partnerships with liquidity hubs like Morpho has made some tokenized assets more usable for lending.
Despite this, in the past month, most tokenization venues saw increased value locked, based on newly minted tokens and appreciating asset prices.
RWA tokenization sets new records RWA tokenization has not slowed its inflows, despite the overall low sentiment in crypto markets. Tokenized commodities are seen as an alternative to riskier altcoins or tokens.
Tokenized US Treasury debt is still the leading asset class, moving closer to $11B in value locked. Tokenized commodities and private credit retain their fast growth rate. In total, the RWA market has grown to $336.76B, of which public equity is still at $1.3B.
Niche asset classes like real estate, talent, and luxury goods are still the smallest source of inflows. Despite this, real estate remains one of the growing use cases for local projects.
Hong Kong approves real estate tokenization Real estate tokenization has been attempted multiple times in the early crypto days, while waiting on shifting regulations. Hong Kong is changing the standard with the recent tokenization of real estate by DL Holdings.
📢 Hong Kong’s first commercial real estate RWA approved
On Feb 26, 2026, DL Holdings (https://t.co/F2PHhSpjmj) announced that the SFC approved two RWA tokenization initiatives:
DL Tower (Central, Hong Kong)⁰Animoca Brands LPF
The holding will tokenize $40M of its stock, thus giving indirect exposure to its portfolio of luxury real estate.
The Hong Kong SFC gave approval to the business plans, though with no further comments on the viability of tokenization or the investment’s security. DL Holdings is already compliant with its listing requirements, making tokenization an external factor outside the scrutiny of the SFC.
2026-03-04 12:598d ago
2026-03-04 07:128d ago
Hyperliquid Dominates Weekend Trading with $11.5B in Real World Assets
TLDR Weekend trading on Hyperliquid reached $11.5B while traditional stock markets remained shuttered. Round-the-clock trading of tokenized commodities like gold and oil demonstrates blockchain superiority. Institutional traders embrace instant settlement, avoiding legacy market delays. NYSE announces blockchain platform development to compete with continuous trading. On-chain platforms and stablecoins emerge as critical infrastructure for global trading. Over the weekend, Hyperliquid emerged as the dominant platform for real world asset trading, processing over $11.5 billion in transactions. This remarkable activity unfolded while traditional stock exchanges across the United States, Europe, and Asia were offline. Industry experts now anticipate an accelerated timeline for blockchain adoption within conventional finance.
The weekend’s trading activity showcased the inherent advantages of blockchain technology, which operates continuously without market closures. Hyperliquid facilitated substantial trading in tokenized commodities including gold and crude oil, demonstrating increasing irrelevance of traditional market hours. This development underscores the rising prominence of decentralized platforms in the global financial ecosystem.
Traders gravitated toward Hyperliquid for instantaneous trade execution, eliminating the settlement lags characteristic of traditional finance. Within a single 24-hour period, Tether Gold trading volume surpassed $300 million. Concurrently, prediction market platforms including Kalshi and Polymarket saw significant increases in user engagement.
On-Chain Trading Gains Momentum as Tokenized Assets See Record Activity Institutional investors and hedge funds flocked to Hyperliquid, seeking uninterrupted market access. As traditional venues stayed closed during significant geopolitical developments, blockchain’s operational efficiency became increasingly apparent. Market participants consequently shifted toward platforms delivering perpetual access and immediate settlement.
The platform’s crude oil trading contracts served as primary reference points for tracking live market movements. Major financial publications referenced Hyperliquid pricing data when reporting on commodity fluctuations. This positioned the platform as a legitimate price discovery mechanism independent of traditional exchanges.
Stablecoin infrastructure enabled rapid capital movement while reducing counterparty exposure. Traders leveraged Hyperliquid for unmediated access to tokenized real-world assets. These patterns reveal a pronounced shift in preference toward decentralized financial infrastructure over conventional systems.
Traditional Exchanges Race to Implement Blockchain for 24/7 Operations Intercontinental Exchange, parent company of the New York Stock Exchange, unveiled intentions to develop a continuous blockchain-based trading platform. The proposed system would enable instantaneous settlement of equities and exchange-traded funds across various blockchain networks. This represents a fundamental strategic pivot toward decentralized technology within established financial institutions.
Specific implementation timelines have not been disclosed, with architectural specifications still being finalized. The platform may incorporate both permissioned and permissionless blockchain components to satisfy regulatory requirements while maximizing operational efficiency. This development directly addresses competitive pressures created by platforms like Hyperliquid.
Legacy financial institutions are actively positioning themselves to integrate blockchain infrastructure or risk obsolescence. Stablecoin custody solutions and cryptocurrency derivatives have become indispensable components of contemporary trading operations. The weekend’s extraordinary volume confirmed that real world asset trading is rapidly transitioning to platforms such as Hyperliquid.
Hyperliquid established itself as the primary destination for real world asset trading, validating blockchain technology’s transformative impact on finance. The platform’s $11.5 billion weekend performance highlighted the growing divide between legacy market infrastructure and always-available trading systems. This momentum now compels traditional finance to accelerate on-chain integration.
Oliver Dale
Editor-in-Chief of Blockonomi and founder of Kooc Media, A UK-Based Online Media Company. Believer in Open-Source Software, Blockchain Technology & a Free and Fair Internet for all. His writing has been quoted by Nasdaq, Dow Jones, Investopedia, The New Yorker, Forbes, Techcrunch & More. Contact [email protected]
Your day-ahead look for March 4, 2026 Mar 4, 2026, 12:15 p.m.
Bitcoin rocketed above $71,000 (WikiImages/Pixabay modified by CoinDesk)What to know: If you're not already subscribed to the newsletter email, click here.
By Omkar Godbole (All times ET unless indicated otherwise)
Bitcoin BTC$71,160.86 rose to just short of $72,000, hitting a one-month high and lifting the broader crypto market even as the war in the Middle East wreaks havoc on traditional markets.
The outperformance stems from several factors, including relative positioning, rising odds of the passage of the U.S.'s long‑debated Clarity Act aimed at legalizing stablecoins and hopes that conflict with Iran will end soon.
Bitcoin, down nearly 50% from its record high in October, was oversold before hostilities began Saturday. So as traditional assets tumbled, BTC held up well. That has likely revived investor interest in the largest cryptocurrency, drawing institutions back to the spot ETFs.
As noted on Monday, bitcoin stands to gain because the war will only worsen government finances worldwide, leading to more "fiat debasement."
Meanwhile, the New York Times put out an interesting report that likely aided the price bounce, according to Bloomberg. The report said that the day after the attacks began, operatives from Iran’s Ministry of Intelligence contacted the CIA to discuss terms for ending the war. While the U.S. ignored the overture, the outreach suggests backchannels are still active and could be used again, potentially leading to a ceasefire.
Lastly, there's the possibility the Clarity Act could be passed soon.
"There was speculation circulating in the U.S. that the Clarity Act was close to being signed into law. This helped lift many altcoins relative to major assets, as they are expected to be among the biggest long-term beneficiaries of the legislation," Paul Howard, director at trading firm Wincent, said in an email.
However, he added that there is currently no strong evidence that a large pool of sidelined money is waiting to flood into digital assets, and any rotation is still relatively small or gradual.
Looking ahead, traders expect volatility to persist, particularly if the Strait of Hormuz, a key oil-supply chokepoint, remains closed and oil prices continue to surge.
"We expect continued volatility, but if the disruption persists, pressure to reopen Hormuz is likely to build. Bitcoin has held up better than broader risk, and bears watching as an early signal of stabilizing sentiment," QCP Capital's market insight team said. Stay alert!
Read more: For analysis of today's activity in altcoins and derivatives, see Crypto Markets Today
What to WatchFor a more comprehensive list of events this week, see CoinDesk's "Crypto Week Ahead".
CryptoMarch 4: Qubic begins testing parallel dogecoin mining and AI trainingMacroMarch 4, 8:15 a.m.: U.S. ADP employment change for February (Prev. 22K)March 4, 10:00 a.m.: U.S. ISM services PMI for February (Prev. 53.8)March 4, 2:00 p.m.: U.S. Fed Beige Book Earnings (Estimates based on FactSet data)Nothing scheduled.Token EventsFor a more comprehensive list of events this week, see CoinDesk's "Crypto Week Ahead".
Governance votes & callsUniswap DAO is voting across two linked proposals to expand v2 and v3 protocol fees to eight layer-2 networks and enable a new tier-based fee system across all v3 pools. Voting ends March 4 & 5.ENS DAO is voting to replace three DNSSEC oracle algorithms to patch a critical RSA signature forgery vulnerability and significantly reduce gas costs. Voting ends March 4.UnlocksNo major unlocks.Token LaunchesMarch 4: Block Street (BSB) to list on Binance Alpha, Bybit, others.ConferencesFor a more comprehensive list of events this week, see CoinDesk's "Crypto Week Ahead".
Day 1 of 3: Quant 2026 (Varese, Italy)Market MovementsBTC is up 4.49% from 4 p.m. ET Wednesday at $71,283.58 (24hrs: +6.65%)ETH is up 5.19% at $2,068.65 (24hrs: +5.64%)CoinDesk 20 is up 4.31% at 3,086.55 (24hrs: +5.45%)Ether CESR Composite Staking Rate is down 1 bps at 2.85%BTC funding rate is at 0.0051% (5.6119% annualized) on BinanceDXY is down 0.25% at 98.81Gold futures are up 1.70% at $5,194.10Silver futures are up 4.00% at $86.24Nikkei 225 closed down 3.61% at 54,245.54Hang Seng closed down 2.01% at 25,249.48FTSE 100 is up 0.18% at 10,502.97Euro Stoxx 50 is up 0.70% at 5,812.08DJIA closed on Tuesday down 0.83% at 48,501.27S&P 500 closed down 0.94% at 6,816.63Nasdaq Composite closed down 1.02% at 22,516.69S&P/TSX Composite closed down 2.19% at 33,784.90S&P 40 Latin America closed down 4.95% at 3,539.33U.S. 10-Year Treasury rate is up 1 bps at 4.06%E-mini S&P 500 futures are unchanged at 6,825.00E-mini Nasdaq-100 futures are unchanged at 24,762.00E-mini Dow Jones Industrial Average futures are down 0.12% at 48,501.00Bitcoin StatsBTC Dominance: 59.61% (+0.81%)Ether-bitcoin ratio: 0.02909 (0.26%)Hashrate (seven-day moving average): 1,025 EH/sHashprice (spot): $31.26Total fees: 2.71 BTC / $183,733CME Futures Open Interest: 101,620 BTCBTC priced in gold: 13.7 oz.BTC vs gold market cap: 4.77%Technical AnalysisBTC's weekly chart in candlestick format. (TradingView)The chart shows bitcoin's weekly price swings in candlestick format from early 2024. The bounce above $71,000 has renewed focus on the $74,000 level, which acted as resistance, an area where buyers tapped out in March 2024 and later as support, where selling stalled last April.This level, therefore, represents an area of significant historical economic activity and could now serve as a key inflection zone: A break and hold above $74,000 may open the door to a push toward higher levels, while repeated failure there could reignite selling pressure.Crypto EquitiesCoinbase Global (COIN): closed on Tuesday at $182.36 (–1.55%), +6.66% at $194.51 in pre-marketGalaxy Digital (GLXY): closed at $20.68 (–4.83%), +4.01% at $21.51MARA Holdings (MARA): closed at $8.66 (–8.36%), +6.47% at $9.22Riot Platforms (RIOT): closed at $15.29 (–6.94%), +3.53% at $15.83Core Scientific (CORZ): closed at $15.30 (–7.22%), +2.55% at $15.69CleanSpark (CLSK): closed at $9.89 (–6.26%), +4.25% at $10.31Exodus Movement (EXOD): closed at $10.83 (+3.44%), +0.65% at $10.90CoinShares Bitcoin Mining ETF (WGMI): closed at $37.88 (–6.31%), +4.67% at $39.65Circle Internet Group (CRCL): closed at $99.63 (+3.63%), +6.15% at $105.76Bullish (BLSH): closed at $33.12 (–2.04%), +2.93% at $34.09Crypto Treasury Companies
Strategy (MSTR): closed at $132.68 (–3.61%), +7.70% at $142.89Upexi (UPXI): closed at $0.79 (–10.80%), +14.65% at $0.90Lite Strategy (LITS): closed at $1.15 (+2.68%)Sharplink (SBET): closed at $7.26 (–1.76%), +4.68% at $7.60ETF FlowsSpot BTC ETFs
Daily net flows: $225.2 millionCumulative net flows: $55.47 billionTotal BTC holdings ~1.28 millionSpot ETH ETFs
Daily net flows: -$10.8 millionCumulative net flows: $11.66 billionTotal ETH holdings ~5.71 millionSource: Farside Investors
While You Were SleepingThe Iran war is dialing U.S. economic danger up to 11 (Bloomberg): President Trump’s extraordinary gamble in attacking Iran and risking a wider conflagration in the Middle East dials up the economic hazards facing the U.S. economy from “very high” to “extreme.”Oil shock fear hits Asian tech stocks while European selloff pauses (Reuters): Selling in hard-hit European shares paused as the focus shifted to Asia, including a record-breaking crash in Seoul caused by fears the broadening Middle East war will create an oil-price shock, raising inflation and delaying interest-rate cuts.Trump urges passage of U.S. Clarity Act, attacks banks for 'undercutting' GENIUS (CoinDesk): Trump said: “We are not going to allow them (banks) to undermine our powerful Crypto Agenda that will end up going to China, and other Countries if we don’t get The Clarity Act taken care of.”Kraken becomes first crypto firm to win access to Fed’s core payments system (The Wall Street Journal): Kraken said its banking unit won access to the Federal Reserve’s core payment systems, making it the first crypto firm to be able to move money on the same rails used by thousands of banks and credit unions.More For You
CoinDesk Research looks into how Pudgy Penguins disrupts traditional toys market via a phygital model. With 2M+ units sold, they scale via global partnerships and events.
What to know:
Disrupting a Stagnant Market: Pudgy Penguins is utilizing a "Negative CAC" model to challenge the traditional $31.7B licensed toy industry by treating physical merchandise as a profitable user acquisition tool rather than just a final product.More For You
Oil shock and inflation fears drag down bitcoin
Mar 3, 2026
Your day-ahead look for March 3, 2026
What to know:
If you're not already subscribed to the newsletter email, click here.